Abstract:
This chapter reviews the occurrence, distribution, metabolism, transport, and actions of the simple sulphur-containing nonproteinaceous amino acid taurine. It is a ubiquitous constituent of virtually all animal cells, particularly enriched in the electrically excitable cells of the nervous system, retina, heart, and muscles. Taurine is present in both neuronal and glial cells, exhibiting moderate regional and cellular variations. It is partly synthesized in situ, but the main supply to the central nervous system (CNS) is from blood plasma. Taurine is taken up by the brain via a saturable transporter and penetrates cells requiring Na+ and Cl−. The release is fomented by cell swelling, depolarizing stimuli, and various cell-damaging conditions.
Taurine interferes with both GABAA and glycine receptors, depending on their subunit composition and amino acid structure. It also affects GABAB receptors, at least in specific structures. The existence of specific taurine receptors and the function of taurine as a neurotransmitter await further investigation. A number of taurine derivatives have been synthesized and tested for their efficacy in counteracting seizures, ameliorating ischemia-induced damage, and protecting neural cells from the toxic actions of xenobiotics. This is an area of research, which may produce new drugs and therapeutic strategies in the future.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AMPA:
-
(±)-2-amino-3-hydroxy-5-methylisoxazole-4-propionate
- cGMP:
-
cyclic GMP
- CNS:
-
central nervous system
- CPP:
-
3-[(±)-2-carboxypiperazin-4-yl]propyl-1-phosphonate
- CSF:
-
cerebrospinal fluid
- DIDS:
-
diisothiocyanostilbene-2,2′-disulfonate
- DOPAC:
-
dihydroxyphenylacetic acid
- GABA:
-
γ-aminobutyric acid
- GES:
-
guanidinoethanesulfonate
- LLP-TAU:
-
taurine-induced long-lasting potentiation
- L-NAME:
-
N G-nitro-l-arginine methylester hydrochloride
- MPP+ :
-
1-methyl-4-phenylpyridinium
- PKA:
-
protein kinase A
- PKC:
-
protein kinase C
- SITS:
-
4-acetamido-4′-isothiocyanostilbene-2,2′-disulfonate
- TAG:
-
taurine antagonist
- TUG1:
-
taurine-upregulated gene 1
References
Abraham JH, Schousboe A. 1989. Effects of taurine on cell morphology and expression of low-affinity GABA receptors in cultured cerebellar granule cells. Neurochem Res 14: 1031–1038.
Aerts L, Van Assche FA. 2002. Taurine and taurine-deficiency in the perinatal period. J Perinat Med 30: 281–286.
Ahmad S, Fowler LJ, Whitton PS. 2004. Effects of acute and chronic lamotrigine treatment on basal and stimulated extracellular amino acids in the hippocampus of freely moving rats. Brain Res 1029: 41–47.
Ahmad S, Fowler LJ, Whitton PS. 2005a. Effects of combined lamotrigine and valproate on basal and stimulated extracellular amino acids and monoamines in the hippocampus of freely moving rats. Naunyn Schmiedebergs Arch Pharmacol 371: 1–8.
Ahmad S, Fowler LJ, Whitton PS. 2005b. Lamotrigine, carbamazepine and phenytoin differentially alter extracellular levels of 5-hydroxytryptamine, dopamine and amino acids. Epilepsy Res 63: 141–149.
Ahtee L, Vahala, ML. 1985. Taurine and its derivatives alter brain dopamine metabolism similarly to GABA in mice and rats. Prog Clin Biol Res 179: 331–341.
Ahtee L, Auvinen H, Mäenpää AR, Vahala ML, Lehtinen M, et al. 1985. Comparison of central nervous system actions of taurine and N-pivaloyltaurine. Acta Pharmacol Toxicol 57: 96–105.
Airaksinen EM, Koivisto K, Keränen T, Pitkänen A, Riekkinen PJ, et al. 1987. Biochemical and clinical studies on epileptic patients during two phase I trials with the novel anticonvulsant taltrimide. Epilepsy Res 1: 308–311.
Airaksinen EM, Oja SS, Marnela KM, Leino E, Pääkkönen L. 1980. Effects of taurine treatment on epileptic patients. Prog Clin Biol Res 3: 157–166.
Albrecht J. 1998. Roles of neuroactive amino acids in ammonia neurotoxicity. J Neurosci Res 51: 133–138.
Albrecht J, Schousboe, 2005. Taurine interaction with neurotransmitter receptors in the CNS: An update. Neurochem Res 30: 1615–1621.
Albrecht J, Bender AS, Norenberg MD. 1994. Ammonia stimulates the release of taurine from cultured astrocytes. Brain Res 660: 288–292.
Albrecht J, Simmons M, Dutton GR, Norenberg MD. 1991. Aluminium chloride stimulates the release of endogenous glutamate, taurine and adenosine from cultured rat cortical astrocytes. Neurosci Lett 127: 105–107.
Alford C, Cox H, Wescott R. 2001. The effects of Red Bull energy drink on human performance and mood. Amino Acids 21: 139–150.
Allen JW, Mutkus LA, Aschner M. 2002. Chronic ethanol produces increased taurine transport and efflux in cultured astrocytes. Neurotoxicology 23: 693–700.
Altshuler D, Lo Turco JJ, Rush J, Cepko C. 1993. Taurine promotes the differentiation of a vertebrate retinal cell type in vitro. Development 119: 1317–1328.
Ament ME, Geggel HS, Heckenlively JR, Martin DA, Kopple JD. 1986. Taurine supplementation in infants receiving long-term total parenteral nutrition. J Am Coll Nutr 5: 127–135.
Andersen L, Sundman LO, Lindén IB, Kontro P, Oja SS. 1984. Synthesis and anticonvulsant properties of some 2-aminoethanesulfonic acid (taurine) derivatives. J Pharm Sci 73: 106–108.
Anderzhanova E, Rayevsky KS, Saransaari P, Riitamaa E, Oja SS. 2001. Effects of sydnocarb and d-amphetamine on the extracellular levels of amino acids in the rat caudate-putamen. Eur J Pharmacol 428: 87–95.
Anderzhanova E, Saransaari P, Oja SS. 2006. Neuroprotective mechanisms of taurine in vivo. Taurine 6. Oja SS, Saransaari P, editors. New York: Springer/Kluwer Academic; pp. 377–387.
Anyanwu E, Harding GF. 1993. The involvement of taurine in the action mechanism of sodium valproate (VPA) in the treatment of epilepsy. Acta Physiol Pharmacol Ther Latinoamer 43: 20–27.
Aragón CM, Amit Z. 1993. Taurine and ethanol-induced conditioned taste aversion. Pharmacol Biochem Behav 44: 236–263.
Aragón CM, Trudeau LE, Amit Z. 1992. Effect of taurine on ethanol-induced changes in open-field locomotor activity. Psychopharmacology 107: 337–340.
Aschner, M. 1997. Astrocyte metallothioneins (MTs) and their neuroprotective role. Ann N Y Acad Sci 825: 334–347.
Aschner M, Vitarella D, Allen JW, Conklin DR, Cowan KS. 1998. Methylmercury-induced inhibition of regulatory volume decrease in astrocytes: Characterization of osmoregulatory efflux and its reversal by amiloride. Brain Res 811: 133–142.
Barabás P, Kovács I, Kardos J, Schousboe A. 2003. Exogenous glutamate and taurine exert differential actions on light-induced release of two endogenous amino acids in isolated rat retina. J Neurosci Res 73: 731–736.
Barakat L, Wang D, Bordey A. 2002. Carrier-mediated uptake and release from Bergman glia in rat cerebellar slices. J Physiol 541: 753–767.
Basavappa S, Mobasheri A, Errington R, Huang CC, Al-Adawi S, et al. 1998. Inhibition of Na+, K+-ATPase activates swelling-induced taurine efflux in a human neuroblastoma cell line. J Cell Physiol 174: 145–153.
Beckman ML, Quick MW. 1998. Neurotransmitter transporters: Regulators of function and functional regulation. J Membr Biol 164: 1–10.
Becquet D, Hery M, Francois-Bellan AM, Giraud P, Deprez P, et al. 1993. Glutamate, GABA, glycine and taurine modulate serotonin synthesis and release in rostral and caudal rhombencephalic raphe cells in primary cell cultures. Neurochem Int 23: 269–283.
Beetsch JW, Olson JE. 1996. Hyperosmotic exposure alters total taurine quantity and cellular transport in rat astrocyte cultures. Biochim Biophys Acta 1290: 141–148.
Beetsch JW, Olson JE. 1998. Taurine synthesis and cysteine metabolism in cultured rat astrocytes: Effects of hyperosmotic exposure. Am J Physiol 274: C866–C874.
Belfer I, Davidson E, Ratner A, Beery E, Shir Y, et al. 1998. Dietary supplementation with the inhibitory amino acid taurine suppresses autonomy in HA rats. Neuroreport 13: 3103–3107.
Belluzzi D, Puopolo M, Benedusi M, Kratskin I. 2004. Selective neuroinhibitory effects of taurine in slices of rat main olfactory bulb. Neuroscience 124: 929–944.
Ben-Ari Y. 2002. Excitatory actions of GABA during development: The nature of the nurture. Nature Rev 3: 728–739.
Benrabh H, Bourre JM, Lefauconnier JM. 1995. Taurine transport at blood-brain barrier: An in vivo brain perfusion study. Brain Res 692: 57–65.
Beyer C, Banas C, Gomora P, Komisurak BR. 1988. Prevention of the convulsant and hyperalgesic action of strychnine by intrathecal glycine and related amino acids. Pharmacol Biochem Behav 29: 73–78.
Beyer C, Banas C, Gonzalez-Flores O, Komisaruk BR. 1989. Blockage of substance P-induced scratching behavior in rats by the intrathecal administration of inhibitory amino acid agonists. Pharmacol Biochem Behav 34: 491–495.
Bianchi L, Colivicchi MA, Bolami JP, Della Corte L. 1998. The release of amino acids from rat neostriatum and substantia nigra in vivo: A dual microdialysis probe analysis. Neuroscience 87: 171–180.
Bianchi L, Colivicchi MA, Ballini C, Fattori M, Venturi C, et al. 2006. Taurine 6. Oja SS, Saransaari P, editors. New York: Springer/Kluwer Academic; pp. 443–448.
Biggs CS, Fowler LJ, Whitton PS, Starr MS. 1995. Impulse-dependent and tetrodotoxin-sensitive release of GABA in the rat's substantia nigra measured by microdialysis. Brain Res 684: 172–178.
Bikjdaouene L, Escames G, León J, Ferrer JMR, Khaldy H, et al. 2003. Changes in brain amino acids and nitric oxide after melatonin administration in rats with pentylenetetrazol-induced seizures. J Pineal Res 35: 54–60.
Birdsall TC. 1998. Therapeutic applications of taurine. Altern Med Rev 3: 128–136.
Bitoun M, Tappaz M. 2000a. Gene expression of the transporters and biosynthetic enzymes of the osmolytes in astrocyte primary cultures exposed to hyperosmotic conditions. Glia 32: 165–176.
Bitoun M, Tappaz M. 2000b. Taurine down-regulates basal and osmolarity-induced gene expression of its transporter, but not the gene expression of its biosynthetic enzymes, in astrocyte primary cultures. J Neurochem 75: 919–924.
Bitoun M, Tappaz M. 2000c. Gene expression of taurine transporter and taurine biosynthetic enzymes in brain of rats with acute or chronic hyperosmotic plasma. A comparative study with gene expression of myo-inositol transporter, betaine transporter and sorbitol. Brain Res Mol Brain Res 77: 10–18.
Bittner S, Win T, Gupta R. 2005. γ-l-Glutamyltaurine. Amino Acids 28: 343–356.
Böckelmann R, Reiser M, Wolf G. 1998. Potassium-stimulated taurine release and nitric oxide synthase activity during quinolinic acid lesion of the rat striatum. Neurochem Res 23: 469–475.
Boldyrev AA, Johnson P, Wei Y, Tan Y, Carpenter DO. 1999. Carnosine and taurine protect rat cerebellar granular cels from free radical damage. Neurosci Lett 263: 169–172.
Borden LA, Smith KE, Vaysse PJ, Gustafson EL, Weinshank RL, et al. 1995. Re-evaluation of GABA transport in neuronal and glial cell cultures: Correlation of pharmacology and mRNA localization. Receptors Channels 3: 129–146.
Brès V, Hurbin A, Duvoid A, Orcel H, Moos FC, et al. 2000. Pharmacological characterization of volume-sensitive, taurine permeable anion channel in rat supraoptic glial cells. Br J Pharmacol 130: 1976–1982.
Bridges CC, Ola MS, Prasad PD, EL-Sherbeny A, Ganapathy V, Smith SB. 2001. Regulation of transporter expression by NO in cultured human retinal pigment epithetial cells. Am J phusiol Cell Physiol 287: C1825-1836.
Bureau MH, Olsen RW. 1991. Taurine acts on a subclass of GABAA receptors in mammalian brain in vitro. Eur J Pharmacol 207: 9–16.
Büyükuysal RL. 2004. Ischemia and reoxygenation-induced amino acid release and tissue damage in the slices of rat corpus striatum. Amino Acids 27: 57–67.
Cardin V, Peña-Segura C, Pasantes-Morales H. 1999. Activation and inactivation of taurine efflux in hyposmotic and isosmotic swelling in cortical astrocytes: Role of ionic strength and cell volume decrease. J Neurosci Res 56: 659–667.
Chaput MA, Palouzier-Paulignan B, Delaleu JC, Duchamp-Viret P. 2004. Taurine action on mitral cell activity in the frog olfactory bulb in vivo. Chem Senses 29: 83–91.
Chen D-Z, Oheuma, Kurizama K. 1996. Characteristics of nitric oxide-evoked [3H]taurine release from cerebral cortial neurons. Neurochem Int 28: 110-117.
Chen WQ, Jin H, Nguyen M, Carr J, Lee YJ, et al. 2001. Role of taurine in regulation of intracellular calcium level and neuroprotective function in cultured neurons. J Neurosci Res 66: 612–619.
Chen XC, Pan ZL, Liu DS, Han X. 1998. Effect of taurine on human fetal neuron cells: Proliferation and differentiation. Adv Med Exp Biol 442: 397–403.
Chepkova AN, Doreulee N, Yanovsky Y, Mukhopadhyay D, Haas HL, et al. 2002. Long-lasting enhancement of corticostriatal neurotransmission by taurine. Eur J Neurosci 16: 1523–1530.
Chepkova AN, Sergeeva OA, Haas HL. 2005. Long-lasting enhancement of corticostriatal transmission by taurine: Role of dopamine and acetylcholine. Cell Mol Neurobiol 25: 767–776.
Chepkova AN, Sergeeva OA, Haas HL. 2006. Mechanisms of long-lasting enhancement of corticostriatal neurotransmission by taurine. Taurine 6. Oja SS, Saransaari P, editors. New York: Springer/Kluwer Academic; pp. 401–410.
Chesney RW, Gusowski N, Dabbaugh S. 1985. Renal cortex taurine regulates the adaptive response to altered dietary intake of sulfur amino acids. J Clin Invest 76: 2213–2221.
Chesney RW, Helms RA, Christensen M, Budreau AM, Han X, et al. 1998. The role of taurine in infant nutrition. Adv Exp Med Biol 442: 463–476.
Chung SJ, Ramanathan V, Giacomini KM, Brett CM. 1994. Characterization of a sodium-dependent taurine transporter in rabbit choroid plexus. Biochim Biophys Acta 1193: 10–16.
Chung SJ, Ramanathan VK, Brett CM, Giacomini KM. 1996. Saturable disposition of taurine in the rat cerebrospinal fluid. J Pharmacol Exp Ther 276: 676–682.
Cocker SE, Lake N. 1987. Electroretinographic alterations and their reversal in rats treated with guanidinoethyl sulfonate, a taurine depletory. Exp Eye Res 45: 977–987.
Cocker SE, Lake N. 1989. Effects of dark maintenance on retinal biochemistry and function during taurine depletion in the adult rats. Vis Neurosci 3: 33–38.
Colivicchi MA, Bianchi L, Boloam JP, Galeffi F, Frosini M, et al. 1998. The in vivo release of taurine in the striatonigral pathway. Adv Exp Med Biol 442: 363–370.
Coloso RM, Hirschberger LL, Dominy JE, Lee JI, Stipanuk MH. 2006. Cysteamine dioxygenase: Evidence for the physiological conversion of cysteamine to hypotaurine in rat and mouse tissues. Taurine 6. Oja SS, Saransaari P, editors. New York: Springer/Kluwer Academic; pp. 25–35.
Cook AM, Denger K. 2006. Metabolism of taurine in microorganisms. A primer in molecular biodiversity. Taurine 6. Oja SS, Saransaari P, editors. New York: Springer/Kluwer Academic; pp. 3–13.
Cordoba J, Gottstein J, Blei AT. 1998. Chronic hyponatremia exacerbates ammonia-induced brain edema in rats after portacaval anastomosis. J Hepatol 29: 589–594.
Cubillos S, Fazzino F, Lima L. 2002. Medium requirements for neuritic outgrowth from goldfish retinal explants and the trophic effect of taurine. Int J Dev Neurosci 20: 607–617.
Cubillos S, Obregón F, Fernanda Vargas M, Salazar LA, Lima L. 2006. Taurine concentration in human gliomas and meningiomas: Tumoral, peritumoral, and extratumoral tissue. Taurine 6. Oja SS, Saransaari P, editors. New York: Springer/Kluwer Academic; pp. 419–422.
Cubillos S, Urbina M, Lima L. 2000. Differential taurine effect on outgrowth from goldfish retinal ganglion cells after optic crush or axotomoy. Influence of the optic tectum. Int J Dev Neurosci 18: 843–853.
Cunningham C, Tipton KF, Dixon HBF. 1998. Conversion of taurine into N-chlorotaurine (taurine chloramines) and sulphoacetaldehyde in response to oxidative stress. Biochem J 330: 939–945.
Dahchour A, De Witte P. 2000a. Ethanol and amino acids in the central nervous system: Assessment of the pharmacological actions of acamprosate. Prog Neurobiol 60: 343–362.
Dahchour A, De Witte P. 2000b. Taurine blocks the glutamate increase in the nucleus accumbens microdialysate of ethanol-dependent rats. Pharmacol Biochem Behav 65: 345–350.
Dahchour A, Quartemont E, De Witte P. 1994. Acute ethanol increases taurine but neither glutamate nor GABA in the nucleus accumbens of male rats: A microdialysis study. Alcohol Alcohol 29: 485–487.
Dahchour A, Quartemont E, De Witte P. 1996. Taurine increases in the nucleus accumbens microdialysate after acute ethanol administration to naive and chronically alcoholised rats. Brain Res 735: 9–19.
David-Watine B, Goblet C, de Saint Jan D, Fucile S, Devignot V, et al. 1999. Cloning, expression and electrophysiological characterization of glycine receptor α subunit from zebrafish. Neuroscience 90: 303–317.
Dawson R Jr, Baker D, Eppler B, Tang E, Shih D, et al. 2000. Taurine inhibition of metal-stimulated catecholamine oxidation. Neurotox Res 2: 1–15.
Dawson R Jr, Pelleymounter MA, Cullen MJ, Gollub M, Liu S. 1999a. An age-related decline in striatal taurine is correlated with a loss of dopaminergic markers. Brain Res Bull 48: 319–324.
Dawson R Jr, Liu S, Eppler B, Patterson T. 1999b. Effects of dietary taurine supplementation or deprivation in aged male Fischer 344-rats. Mech Ageing Dev 107: 73–91.
Decavel C, Hatton GI. 1995. Taurine immunoreactivity in the rat supraoptic nucleus: Prominent localization in glial cells. J Comp Neurol 354: 13–26.
Deleuze C, Alonso G, Lefevre IA, Duvoid-Guillou A, Hussy N. 2005. Extrasynaptic localization of glycine receptors in the rat supraoptic nucleus: Further evidence for their involvement in glia-to-neuron communication. Neuroscience 133: 175–183.
Della Corte L, Bolam JP, Clarke DJ, Parry DM, Smith AD. 1990. Sites of [3H]taurine uptake in the rat substantia nigra in relation to the release of taurine from the nigrostriatal pathway. Eur J Neurosci 2: 50–61.
Della Corte L, Crichton RR, Duburs G, Nolan K, Tipton KF, et al. 2002. The use of taurine analogues to investigate taurine functions and their potential therapeutic applications. Amino Acids 23: 367–379.
del Olmo N, Bustamante J, MartÃn del RÃo R, SolÃs JM. 2000a. Taurine activates GABAA but not GABAB receptors in rat hippocampal CA1 area. Brain Res 864: 298–307.
del Olmo N, Galarreta M, Bustamante J, MartÃn del RÃo R, SolÃs JM. 2000b. Taurine-induced synaptic potentiation: Role of calcium and interaction with LTP. Neuropharmacology 39: 40–54.
del Olmo N, Galarreta M, Bustamante J, MartÃn del RÃo R, SolÃs JM. 2000c. Taurine-induced synaptic potentiation: Dependence on extra- and intracellular taurine sources. Adv Exp Med Biol 483: 283–292.
del Olmo N, Handler A, Alvarez L, Bustamante J, MartÃn del RÃo R, et al. 2003. Taurine-induced synaptic potentiation and the late phase of long-term potentiation are related mechanistically. Neuropharmacology 44: 26–39.
del Olmo N, Suárez LM, Orensanz LM, Suárez F, Bustamante J, et al. 2004. Role of taurine uptake on the induction of long-term synaptic potentiation. Eur J Neurosci 19: 1875–1886.
Devamanoharan PS, Ali AH, Varma SD. 1998. Oxidative stress to rat lens in vitro: Protection by taurine. Free Radic Res 29: 189–195.
Devreker F, Bergh Van den M, Biramane J, Winston RML, Englert Y, et al. 1999. Effects of taurine on human embryo development in vitro. Hum Reprod 14: 2350–2356.
Didier A, Ottersen OP, Storm-Mathisen J. 1994. Differential subcellular distribution of glutamate and taurine in primary olfactory neurons. Neuroreport 6: 145–148.
Diniz C, da Cruz Fresco P, Gonçalves J. 1999. Taurine release in the rat vas deferens is modulated by Ca2+ and is independent of concentrations. Eur J Pharmacol 376: 273–278.
Dohmen C, Kumura E, Rosner G, Heiss WD, Graf R. 2005. Extracellular correlates of glutamate toxicity in short-term cerebral ischemia and reperfusion: A direct in vivo comparison between white and gray matter. Brain Res 1017: 43–51.
Dominy J Jr, Thinschmidt JS, Peris J, Dawson R Jr, Papke RL. 2004. Taurine-induced long-lasting potentiation in the rat hippocampus shows a partial dissociation from total hippocampal taurine content and independence from activation of known taurine transporters. J Neurochem 89: 1195–1205.
El-Abhar HS, Abd El Gawad HM. 2003. Modulation of cortical nitric oxide synthase, glutamate, and redox state by nifedipine and taurine in PTZ-kindled mice. Epilepsia 44: 276–281.
El Idrissi A. 2006. Taurine and brain excitability. Taurine 6. Oja SS, Saransaari P, editors. New York: Springer/Kluwer Academic; pp. 315–322.
El Idrissi A, Trenkner E. 1999. Growth factors and taurine protect against excitotoxicity by stabilizing calcium homeostasis and energy metabolism. J Neurosci 19: 9459–9468.
El Idrissi A, Trenkner E. 2003. Taurine regulates mitochondrial calcium homeostasis. Adv Exp Med Biol 526: 527–536.
El Idrissi A, Trenkner E. 2004. Taurine as a modulator of excitatory and inhibitory neurotransmission. Neurochem Res 29: 189–197.
El Idrissi A, Harris C, Trenkner E. 1998. Taurine modulates glutamate and growth factors-mediated signaling mechanisms. Adv Exp Med Biol 442: 385–396.
El Idrissi A, Messing H, Scalia J, Trenkner E. 2003. Prevention of epileptic seizures by taurine. Adv Exp Med Biol 526: 515–525.
Engelmann M, Landgraf R, Wotjak CT. 2003. Taurine regulates corticotropin secretion at the level of the supraoptic nucleus during stress in rats. Neurosci Lett 348: 120–122.
Engelmann M, Wolf G, Horn TFW. 2002. Release patterns of excitatory and inhibitory amino acids within the hypothalamic supraoptic nucleus in response to direct nitric oxide administration during forced swimming in rats. Neurosci Lett 324: 252–254.
Eppler B, Patterson TA, Zhou W, Millard WJ, Dawson R Jr. 1999. Kainic acid (KA)-induced seizures in Sprague-Dawley rats and the effect of dietary taurine (TAU) supplementation or deficiency. Amino Acids 16: 133–147.
Erikson K, Aschner M. 2002. Manganese causes differential regulation of glutamate transporter (GLAST), taurine transporter and metallothionein in cultured rat astrocytes. Neurotoxicology 23: 595–602.
Erikson KM, Suber RL, Aschner M. 2002. Glutamate/aspartate transporter (GLAST), taurine transporter and metallothionein mRNA levels are differentially altered in astrocytes exposed to manganese chloride, manganese phosphate or manganese sulfate. Neurotoxicology 23: 281–288.
Estevez AY, O'Regan MH, Song D, Phillis JW. 1999a. Hyposmotically induced amino acid release from the rat cerebral cortex: Role of phospholipases and protein kinases. Brain Res 844: 1–9.
Estevez AY, O'Regan MH, Song D, Phillis JW. 1999b. Effects of anion channel blockers on hyposmotically induced amino acid release from the in vivo rat cerebral cortex. Neurochem Res 24: 447–452.
Estevez AY, Song D, Phillis JW, O'Regan MH. 2000. Effects of the anion channel blocker DIDS on ouabain- and high K+-induced release of amino acids from the rat cerebral cortex. Brain Res Bull 52: 45–50.
Faff L, Reichenbach A, Albrecht J. 1996. Ammonia-induced taurine release from cultured rabbit Müller cells is an osmoresistant process mediated by intracellular accumulation of cyclic AMP. J Neurosci Res 46: 231–238.
Faff L, Reichenbach A, Albrecht J. 1997. Two models of stimulation by ammonia of taurine release from cultured rabbit Müller cells. Neurochem Int 31: 301–305.
Faff-Michalak L, Reichenbach A, Dettmer D, Kellner K, Albrecht J. 1994. K+-, hypoosmolarity-, and NH4 +-induced taurine release from cultured rabbit Müller cells: Role of Na+ and Cl− ions and relation to cell volume changes. Glia 10: 114–120.
Fellman JH, Roth ES. 1985. The biological oxidation of hypotaurine to taurine: Hypotaurine as an antioxidant. Prog Clin Biol Res 179: 71–82.
Ferko AP. 1987. Ethanol-induced sleep time: Interaction with taurine and a taurine antagonist. Pharmacol Biochem Behav 27: 235–238.
Ferko AP, Bobyock E. 1988. Effect of taurine on ethanol-induced sleep time in mice genetically bred for differences in ethanol sensitivity. Pharmacol Biochem Behav 31: 667–673.
Flora SJ, Pande M, Bhadauria S, Kannan GM. 2004. Combined administration of taurine and meso-2,3-dimercaptosuccinic acid in the treatment of chronic lead intoxication in rats. Human Exp Toxicol 23: 157–166.
Foos TM, Wu JY. 2002. The role of taurine in the central nervous system and the modulation of intracellular calcium homeostasis. Neurochem Res 27: 21–26.
Franco R, Quesada O, Pasantes-Morales H. 2000. Efflux of osmolyte amino acids during isovolumic regulation in hippocampal slices. J Neurosci Res 61: 701–711.
Franco R, Torres-Márquez ME, Pasantes-Morales H. 2001. Evidence for two mechanisms of amino acid osmolyte release from hippocampal slices. Pflügers Arch Eur J Physiol 442: 791–800.
Franconi F, Diana G, Fortuna A, Galietta G, Trombetta G, et al. 2004. Taurine administration during lactation modifies hippocampal CA1 neurotransmission and behavioural programming in adult male mice. Brain Res Bull 63: 491–497.
Frosini M, Sesti C, Dragoni S, Valoti M, Palmi M, et al. 2003a. Interactions of taurine and structurally related analogues with the GABAergic system and taurine binding sites of rabbit brain. Br J Pharmacol 138: 1163–1171.
Frosini M, Sesti C, Saponara S, Ricci L, Valoti M, et al. 2003b. A specific taurine recognition site in the rabbit brain is responsible for taurine effects on thermoregulation. Br J Pharmacol 139: 487–494.
Frosini M, Sesti C, Palmi M, Valoti M, Fusi F, et al. 2000a. Heat-stress-induced hyperthermia alters CSF osmolality and composition in conscious rabbits. Am J Physiol Regul Integr Comp Physiol 279: 2095–2103.
Frosini M, Sesti C, Saponara S, Donati A, Palmi M, et al. 2000b. Effects of taurine and some structurally related analogues on the central mechanism of thermoregulation. A structure-activity relationship study. Adv Exp Med Biol 483: 273–282.
Galarreta M, Bustamante J, MartÃn del RÃo R, SolÃs JM. 1996a. A new neuromodulatory action of taurine: Long-lasting increase of synaptic potentials. Adv Exp Med Biol 403: 463–471.
Galarreta M, Bustamante J, MartÃn del RÃo R, SolÃs JM. 1996b. Taurine induces a long-lasting increase of synaptic efficacy and axon excitability in the hippocampus. J Neurosci 16: 92–102.
Galietta LJ, Falzoni S, Di Virgilio F, Romeo G, Zegarra-Moran O. 1997. Characterization of volume-sensitive taurine- and Cl−-permeable channels. Am J Physiol 273: C57–C66.
Ganapathy V, Ramamoorthy JD, Del Monte MA, Leibach FH, Ramamoorthy S. 1995. Cyclic AMP-dependent up-regulation of the taurine transporter in a human retinal pigment epithelial cell line. Curr Eye Res 14: 843–850.
GarcÃa Dopico J, Perdomo DÃaz J, Alonso TJ, González Hernández T, Castro Fuentes R, et al. 2004. Extracellular taurine in the substantia nigra: Taurine–glutamate interaction. J Neurosci Res 76: 528–538.
Gavrovskaya LK, Krylova IB, Selina EN, Safonova AF, Petrova NN, et al. 2006. Antihypoxic properties of taurinamide derivatives. Taurine 6. Oja SS, Saransaari P, editors. New York: Springer/Kluwer Academic; pp. 523–528.
Geggel HS, Ament ME, Heckenlively JR, Martin DA, Kopple JD. 1985. Nutritional requirement for taurine in patients receiving long-term parenteral nutrition. New Eng J Med 312: 142–146.
Geiss KR, Jester I, Falke W, Hamm M, Waag KL. 1994. The effect of a taurine-containing drink on performance in 10 endurance-athletes. Amino Acids 7: 45–56.
Girard Y, Atkinson JG, Haubrich DR, Williams M, Yarbrough GG. 1982. Aminomethyl-1,2,4-benzothiadiazines as potential analogues of γ-aminobutyric acid. Unexpected discovery of a taurine antagonist. J Med Chem 25: 113–116.
Goda H, Ooboshi H, Nakane H, Ibayashi S, Sadoshima S, et al. 1998. Modulation of ischemia-evoked release of excitatory and inhibitory amino acids by adenosine A1 receptor agonist. Eur J Pharmacol 357: 149–155.
Godfrey DA, Farms WB, Godfrey TG, Mikesell NL, Liu J. 2000. Amino acid concentrations in rat cochlear nucleus and superior olive. Hear Res 150: 189–205.
Goodman HO, Shihabi Z, Oles KS. 1989. Antiepileptic drugs and plasma and platelet taurine in epilepsy. Epilepsia 30: 201–207.
Gragera RR, Muniz E, De Esteban G, Alonso MJ, MartÃnez-RodrÃguez R. 1995. Immunochemical demonstration of taurine in the rat cerebellar cortex. Evidence for its location within mossy fibers and Golgi axons. J Hirnforsch 36: 269–276.
Guevara-Guzman R, Emson PC, Kendrick KM. 1994. Modulation of in vivo striatal transmitter release by nitric oxide and cyclic GMP. J Neurochem 62: 807–810.
Guo J, Zhao P, Xia Y, Zhou F, Yang R, et al. 2006. Involvement of taurine in cerebral ischemia and electroacupuncture anti-ischemia. Taurine 6. Oja SS, Saransaari P, editors. New York: Springer/Kluwer Academic; pp. 395–400.
Gupta RC. 2006. Taurine analogues and taurine transport: Therapeutic advantages. Taurine 6. Oja SS, Saransaari P, editors. New York: Springer/Kluwer Academic; pp. 449–467.
Gupta RC, Win T, Bittner S. 2005. Taurine analogues; a new class of therapeutics: Retrospect and prospects. Curr Med Biol 12: 2021–2039.
Hada J, Kaku T, Morimoto K, Hayashi Y, Nagai K. 1996. Adenosine transport inhibitors enhance high K+-evoked taurine release from rat hippocampus. Eur J Pharmacol 305: 101–107.
Hagberg H, Andersson P, Kjellmer I, Thiringer K, Thordstein M. 1987. Extracellular overflow of glutamate, aspartate, GABA and taurine in the cortex and basal ganglia of fetal lambs during hypoxia-ischemia. Neurosci Lett 78: 311–317.
Haroutounian JE, Petrosian AM. 1998. Effects of taurine and light on retinal GABA content and the efflux of 14C-GABA and 14C-aspartate from frog retina. Adv Exp Med Biol 442: 415–421.
Hashimoto-Kitsukawa S, Okuyama S, Aihara H. 1988a. Enhancing effect of taurine in the rat caudate spindle. I. Interaction of taurine with the nigro-striatal dopamine system. Pharmacol Biochem Behav 31: 411–416.
Hashimoto-Kitsukawa S, Okuyama S, Aihara H. 1988b. Enhancing effect of taurine in the rat caudate spindle. II. Effect of bilateral 6-hydroxydopamine lesions of the nigro-striatal dopamine system. Pharmacol Biochem Behav 31: 417–423.
Hassel B, Taubøll E, Gjerstad L. 2001. Chronic lamotrigine treatment increases rat hippocampal GABA shunt activity and elevates cerebral taurine levels. Epilepsy Res 43: 153–163.
Häuser MA, Yung WH, Lacey MG. 1992. Taurine and glycine activate the same Cl− conductance in substantia nigra dopamine neurons. Brain Res 571: 103–108.
Hayes J, Tipton KF, Bianchi L, Della Corte L. 2001. Complexities in the neurotoxic actions of 6-hydroxydopamine in relation to the cytoprotective properties of taurine. Brain Res Bull 55: 239–245.
Hegstad E, Berg-Johnsen J, Haugstad TS, Hauglie-Hanssen E, Langmoen IA. 1996. Amino-acid release from human cerebral cortex during simulated ischemia in vitro. Acta Neurochir (Wien) 138: 234–241.
Heinämäki AA, Muhonen AS, Piha RS. 1986. Taurine and other free amino acids in the retina, vitreous, lens, iris-ciliary body, and cornea of the rat eye. Neurochem Res 11: 535–542.
Heller-Stilb B, van Roeyen C, Rascher K, Hartwig HG, Huth A, et al. 2002. Disruption of the taurine transporter gene (taut) leads to retinal degeneration in mice. FASEB J 16: 231–233.
Herranz AS, SolÃs JM, Herreras O, Menéndez N, Ambrosio E, et al. 1990. The epileptogenic action of the taurine analogue guanidinoethane sulphonate may be caused by a blockade of GABA receptors. J Neurosci Res 26: 98–104.
Hilgier W, Anderzhanova E, Oja SS, Saransaari P, Albrecht J. 2003. Taurine reduces ammonia- and N-methyl-d-aspartate-induced accumulation of cyclic GMP and hydroxyl radicals in microdialysates of the rat striatum. Eur J Pharmacol 468: 21–25.
Hilgier W, Oja SS, Saransaari P, Albrecht J. 2005. Taurine prevents ammonia-induced accumulation of cyclic AMP in rat striatum by interaction with GABAA and glycine receptors. Brain Res 1043: 242–246.
Hilgier W, Olson JE, Albrecht J. 1996. Relation of taurine transport and brain edema in rats with simple hyperammonemia or liver failure. J Neurosci Res 45: 69–74.
Hilgier W, Zielińska M, Borkowska HD, Gadamski R, Walski M, et al. 1999. Changes in the extracellular profiles of neuroactive amino acids in the rat striatum at the asymptomatic stage of hepatic failure. J Neurosci Res 56: 76–84.
Holopainen I, Kontro P. 1989. Uptake and release of glycine in cerebellar granule cells and astrocytes in primary culture: The potassium-stimulated release from granule cells is Ca-dependent. J Neurosci Res 24: 374–383.
Holopainen I, Kontro P, Frey HJ, Oja SS. 1983. Taurine, hypotaurine, and GABA uptake by cultured neuroblastoma cells. J Neurosci Res 10: 83–92.
Holopainen I, Kontro P, Oja SS. 1985. Release of preloaded taurine and hypotaurine from astrocytes in primary culture: Stimulation by calcium-free media. Neurochem Res 10: 123–131.
Holopainen I, Lidén E, Nilsson A, Sellström Å. 1990. Depolarization of the neuronal membrane caused by cotransport of taurine and sodium. Neurochem Res 15: 89–94.
Hoop B, Beagle JL, Maher TJ, Kazemi H. 1999. Brainstem amino acid transmitters and hypoxic ventilatory response. Respir Physiol 118: 117–129.
Horikoshi T, Asanuma A, Yanagisawa K, Anzai K, Goto S. 1988. Taurine and β-alanine act on both GABA and glycine receptors in Xenopus oocyte injected with mouse brain messenger RNA. Brain Res 464: 97–105.
Horner KC, Aurousseau C. 1997. Immunoreactivity for taurine in the cochlea: Its abundance in supporting cells. Hearing Res 109: 135–142.
Hornfeldt CS, Smullin DH, Schamber CD, Sun X, Larson AA. 1992. Antinociceptive effects of intrathecal taurine and calcium in the mouse. Life Sci 50: 1925–1934.
Hussy N, Brès V, Rochette M, Duvoid A, Alonso G, et al. 2001. Osmoregulation of vasopressin secretion via activation of neurohypophysial nerve terminals glycine receptors by glial taurine. J Neurosci 21: 7110–7116.
Hussy N, Deleuze C, Desarménien MG, Moos FC. 2000. Osmotic regulation of neuronal activity: A new role for taurine and glial cells in a hypothalamic neuroendocrine structure. Prog Neurobiol 62: 113–134.
Hussy N, Deleuze C, Pantaloni A, Desarménien MG, Moos F. 1997. Agonist action of taurine on glycine receptors in rat supraoptic magnocellular neurons: Possible role in osmoregulation. J Physiol 502: 609–621.
Huxtable RJ. 1986. Taurine and the oxidative metabolism of cysteine. Biochemistry of Sulfur. New York: Plenum Press; pp. 121–198.
Huxtable RJ. 1989. Taurine in the central nervous system and the mammalian actions of taurine. Prog Neurobiol 32: 471–533.
Huxtable RJ. 1992. The physiological actions of taurine. Physiol Rev 72: 101–163.
Huxtable RJ, Nakagawa K. 1985. The anticonvulsant actions of two taurine derivatives in genetic and chemically induced seizures. Prog clin Biop Res 179: 435-448.
Imaki H, Moretz RC, Wisniewski HM, Sturman JA. 1986. Feline maternal taurine deficiency: Effects on retina and tapetum of the offspring. Dev Neurosci 8: 160–181.
Imaki H, Moretz RC, Wisniewski HN, Neuringer M, Sturman JA. 1987. Retinal degeneration in three-month-old rhesus monkey infants fed a taurine-free human infant formula. J Neurosci Res 18: 602–614.
Inomata H, Nabekura J, Akaike N. 1993. Suppression of taurine response in acutely dissociated substantia nigra neurons by intracellular cyclic AMP. Brain Res 615: 347–350.
Iwata H, Matsuda T, Lee E, Yamagami S, Baba A. 1980. Effect of ethanol on taurine concentration in the brain. Experientia 36: 332–333.
Iwata H, Nakayama K, Matsuda T, Baba A. 1984. Effect of taurine on a benzodiazepine-GABA-chloride ionophore receptor complex in rat brain membranes. Neurochem Res 9: 535–544.
Izumi H, Kishita C, Nakagawa K, Huxtable RJ, Shimizu T, et al. 1985. Modification of the antiepileptic actions of phenobarbital and phenytoin by the taurine transport inhibitor, guanidinoethane sulfonate. Eur J Pharmacol 110: 219–224.
Jacobsen JG, Smith LH Jr. 1968. Biochemistry and physiology of taurine and taurine derivatives. Physiol Rev 48: 424–511.
Jacobson I, Hamberger A. 1985. Kainic acid-induced changes of extracellular amino acid levels, evoked potentials and EEG activity in the rabbit olfactory bulb. Brain Res 348: 289–296.
Jiang Z, Krnjević K, Wang F, Ye JH. 2004. Taurine activates strychnine-sensitive glycine receptors in neurons freshly isolated from nucleus accumbens of young rats. J Neurophysiol 91: 248–257.
Jones DP, Miller LA, Dowling C, Chesney RW. 1991. Regulation of taurine transporter activity in LLC-PK1 cells: Role of protein synthesis and protein kinase C activation. J Am Soc Nephrol 2: 1021–1029.
Kaehler ST, Sinner C, Kouvelas D, Philippu A. 2000. Effects of inescapable shock and conditioned fear on the release of excitatory and inhibitory amino acids in the locus coeruleus. Naunyn Schmiedebergs Arch Pharmacol 361: 193–199.
Kalloniatis M, Marc RE, Murry FR. 1996. Amino acid signatures in the primate retina. J Neurosci 16: 6807–6829.
Kamisaki Y, Maeda K, Ishimura M, Omura H, Itoh T. 1993. Effects of taurine on depolarization-evoked release of amino acids from rat cortical synaptosomes. Brain Res 627: 181–185.
Kamisaki Y, Wada K, Nakamoto K, Itoh T. 1996a. Effect of taurine on GABA release from synaptosomes of rat olfactory bulb. Amino Acids 10: 49–57.
Kamisaki Y, Wada K, Nakamoto K, Itoh T. 1996b. Release of taurine and its effects on release of neurotransmitter amino acids in rat cerebral cortex. Adv Exp Med Biol 403: 445–454.
Kang YS. 2000. Taurine transport mechanism through the blood-brain barrier in spontaneously hypertensive rats. Adv Exp Med Biol 483: 321–324.
Kang YS. 2006. The effect of oxidative stress on the transport of taurine in an in vitro model of the blood-brain barrier. Taurine 6. Oja SS, Saransaari P, editors. New York: Springer/Kluwer Academic; pp. 291–298.
Kang YS, Ohtsuki S, Takanaga H, Tomi M, Hosoya K, et al. 2002. Regulation of taurine transport at the blood-brain barrier by tumor necrosis factor-α, taurine and hypertonicity. J Neurochem 83: 1188–1195.
Kapoor V, Nakahara D, Blood RJ, Chalmers JP. 1990. Preferential release of neuroactive amino acids from the ventrolateral medulla of the rat in vivo as measured by microdialysis. Neuroscience 37: 187–191.
Kashkin VA, De Witte P. 2004. Ethanol but not acetaldehyde induced changes in brain taurine: A microdialysis study. Amino Acids 26: 117–124.
Katoh H, Sima K, Nawashiro H, Wada K, Chigasaki H. 1997. The effect of MK-801 on extracellular neuroactive amino acids in hippocampus after closed head injury followed by hypoxia in rats. Brain Res 758: 153–162.
Keep RF, Xiang J. 1996. Choroid plexus taurine transport. Brain Res 715: 17–24.
Keys SA, Zimmerman WF. 1999. Antioxidant activity of retinol, glutathione, and taurine in bovine photoreceptor cell membranes. Exp Eye Res 68: 693–702.
Khan SNH, Banigesh A, Baziani A, Todd KG, Miyashita H, et al. 2000. The role of taurine in neuronal protection following transient global forebrain ischemia. Neurochem Res 25: 217–223.
Kilic F, Bhardwaj R, Caulfield J, Trevithick JR. 1999. Modelling cortical cataractogenesis 22: Is in vitro reduction of damage in model diabetic rat cataract by taurine due to its antioxidant activity? Exp Eye Res 69: 291–300.
Kimelberg HK, Cheema M, O'Connor ER, Tong H, Goderie SK, et al. 1993. Ethanol-induced aspartate and taurine release from primary astrocyte cultures. J Neurochem 60: 1682–1689.
Kimelberg HK, Goderie SK, Higman S, Pang S, Waniewski RA. 1990. Swelling-induced release of glutamate, aspartate, and taurine from astrocyte cultures. J Neurosci 10: 1583–1591.
Kimelberg HK, Nestor NB, Feustel PJ. 2004. Inhibition of release of taurine and excitatory amino acids in ischemia and neuroprotection. Neurochem Res 29: 267–274.
Kingston R, Kelly CJ, Murray P. 2004. The therapeutic role of taurine in ischaemia-reperfusion injury. Curr Pharm Des 10: 2401–2410.
Kirchner A, Breustedt J, Rosche B, Heinemann UF, Schmieden V. 2003. Effects of taurine and glycine on epileptiform activity induced by removal of Mg2+ in combined rat entorhinal cortex-hippocampal slices. Epilepsia 44: 1145–1152.
Kluša V, Klimaviciusa L, Duburs G, Poikans J, Zharkovsky A. 2006. Anti-neurotoxic effect of tauropyrone, a taurine analogue. Taurine 6. Oja SS, Saransaari P, editors. New York: Springer/Kluwer Academic; pp. 499–508.
Koivisto K, Sivenius J, Keränen T, Partanen J, Riekkinen P, et al. 1986. Clinical trial with an experimental taurine derivative, taltrimide, in epileptic patients. Epilepsia 27: 87–90.
Kontro P. 1979. Components of taurine efflux in rat brain synaptosomes. Neuroscience 4: 1745–1749.
Kontro P. 1987. Interactions of taurine and dopamine in the striatum. Adv Exp Med Biol 217: 347–355.
Kontro P, Oja SS. 1983. Sodium-independent taurine binding to brain synaptic membranes. Cell Mol Neurobiol 3: 183–187.
Kontro P, Oja SS. 1985a. Hypotaurine oxidation by mouse liver tissue. Prog Clin Biol Res 179: 83–90.
Kontro P, Oja SS. 1985b. Properties of sodium-independent taurine binding to brain synaptic membranes. Prog Clin Biol Res 179: 249–259.
Kontro P, Oja SS. 1986. Taurine interferes with spiperone binding in the striatum. Neuroscience 19: 1007–1010.
Kontro P, Oja SS. 1987a. Taurine and GABA binding in mouse brain: Effects of freezing, washing and Triton X-100 treatment on membranes. Int J Neurosci 32: 881–889.
Kontro P, Oja SS. 1987b. Taurine and GABA release from mouse cerebral cortex slices: Potassium stimulation releases more taurine than GABA from developing brain. Dev Brain Res 37: 277–291.
Kontro P, Oja SS. 1987c. Effects of the anticonvulsant taurine derivative, taltrimide, on membrane transport and binding of GABA and taurine in the mouse cerebrum. Neuropharmacology 26: 19–23.
Kontro P, Oja SS. 1987d. Glycinergic systems in the brain stem of developing and adult mice: Effects of taurine. Int J Dev Neurosci 5: 461–470.
Kontro P, Oja SS. 1987e. Co-operativity in sodium-independent taurine binding to brain membranes in the mouse. Neuroscience 23: 567–570.
Kontro P, Oja SS. 1987f. Effects of the new anticonvulsant taurine derivative, taltrimide, on membrane transport and binding of GABA and taurine in the mouse cerebrum. Neuropharmacology 26: 19–23.
Kontro P, Oja SS. 1988a. Release of taurine, GABA and dopamine from rat striatal slices: Mutual interactions and developmental aspects. Neuroscience 24: 49–58.
Kontro P, Oja SS. 1988b. Effects of taurine on the influx and efflux of calcium in brain slices of adult and developing mice. Int J Neurosci 38: 103–109.
Kontro P, Oja SS. 1989. Release of taurine and GABA from cerebellar slices from developing and adult mice. Neuroscience 29: 413–423.
Kontro P, Oja SS. 1990. Interactions of taurine with GABAB binding sites in mouse brain. Neuropharmacology 29: 243–247.
Kontro P, Korpi ER, Oja OS, Oja SS. 1984. Modulation of noradrenaline uptake and release by taurine in rat cerebral slices. Neuroscience 13: 663–666.
Kontro P, Korpi ER, Oja SS. 1990. Taurine interacts with GABAA and GABAB receptors in the brain. Prog Clin Biol Res 351: 83–94.
Kontro P, Marnela K-M, Oja SS. 1980. Free amino acids in the synaptosome and synaptic vesicle fractions of different bovine brain areas. Brain Res 184: 129–141.
Korpi ER, Kontro P, Nieminen K, Marnela K-M, Oja SS. 1981. Spontaneous and depolarization-induced efflux of hypotaurine from mouse cerebral cortex slices: Comparison with taurine and GABA. Life Sci 29: 811–816.
Kreisman NR, Olson JE. 2003. Taurine enhances volume regulation in hippocampal slices swollen osmotically. Neuroscience 120: 635–642.
Krishtal OA, Osipchuk YV, Vrublevsky SV. 1988. Properties of glycine-activated conductances in rat brain neurons. Neurosci Lett 84: 271–276.
Krylova IB, Bulion VV, Gavrovskaya LK, Selina EN, Kuznetzova NN, et al. 2006. Neuroprotective effect of a new taurinamide derivative–taurepar. Taurine 6. Oja SS, Saransaari P, editors. New York: Springer/Kluwer Academic; pp. 543–550.
Kubo T, Takano A, Tokushige N, Miyata N, Sato M, et al. 1992. Electrical stimulation-evoked release of endogenous taurine from slices of the hippocampus, cerebral cortex and cerebellum of the rat. J Pharmacobiodyn 15: 519–525.
Kudo Y, Akiyoshi E, Akagi H. 1988. Identification of two taurine receptor subtypes on the primary afferent terminal of frog spinal cord. Br J Pharmacol 94: 1051–1056.
Kuhse J, Schmieden V, Betz H. 1990a. Identification and functional expression of a novel ligand binding subunit of the inhibitory glycine receptor. J Biol Chem 265: 22317–22320.
Kuhse J, Schmieden V, Betz H. 1990b. A single amino acid exchange alters the pharmacology of neonatal rat glycine receptor subunit. Neuron 5: 867–873.
Kulanthaivel P, Cool DR, Ramamoorthy S, Mahesh VB, Leibach FH, et al. 1991. Transport of taurine and its regulation by protein kinase C in the JAR human placental choriocarcinoma cell line. Biochem J 277: 53–58.
La Bella V, Piccoli F. 2000. Differential effect of β-N-oxalylamino-l-alanine, the Lathyrus sativus neurotoxin, and (±)-α-amino-3-hydroxy-5-methylisoxazole-4-propionate on the excitatory amino acid and taurine levels in the brain of freely moving rat. Neurochem Int 36: 523–530.
Lähdesmäki P, Oja SS. 1973. On the mechanism of taurine transport at brain cell membranes. J Neurochem 20: 1411–1417.
Lai YJ, Shen EY, Pan WHT. 2000. Effects of ascorbate in microdialysis perfusion medium on the extracellular basal concentration of glutamate in rat's striatum. Neurosci Lett 279: 145–148.
Lake N. 1981. Depletion of retinal taurine by treatment with guanidinoethyl sulfonate. Life Sci 29: 445–448.
Lake N. 1983. Taurine depletion of lactating rats: Effects on developing pups. Neurochem Res 8: 881–887.
Lake N. 1986. Electroretinographic deficits in rats treated with guanidinoethyl sulfonate, a depletor of taurine. Exp Eye Res 42: 87–91.
Lake N. 1992. Localization of taurine and glial fibrillary acidic protein in human optic nerve using immunocytochemical techniques. Adv Exp Med Biol 315: 303–307.
Lake N. 1994. Taurine and GABA in the rat retina during postnatal development. Vis Neurosci 11: 253–260.
Lake N, Cocker SE. 1983. In vitro studies of guanidinoethyl sulfonate and taurine transport in the rat retina. Neurochem Res 8: 1557–1563.
Lake N, De Marte L. 1988. Effects of β-alanine treatment on the taurine and DNA content of the rat heart and retina. Neurochem Res 13: 1003–1006.
Lake N, Orlowski J. 1996. Cellular studies of the taurine transporter. Adv Exp Med Biol 403: 371–376.
Lake N, Verdone-Smith C. 1989. Immunocytochemical localization of taurine in the mammalian retina. Curr Eye Res 8: 163–173.
Lake N, Malik N, De Marte L. 1988. Taurine depletion leads to loss of rat optic nerve axons. Vision Res 28: 1071–1076.
Lake N, Ueck M, Hach A, Verdone-Smith C. 1996. Ultrastructural localization of taurine immunoreactivity in the pineal organ and retina of the pigeon. Adv Exp Med Biol 403: 329–331.
Lake N, Verdone-Smith C, Brownstein S. 1992. Immunocytochemical localization of taurine and glial acidic fibrillary protein in human optic nerve. Vis Neurosci 8: 251–255.
Lallemand F, De Witte P. 2004. Taurine concentration in the brain and in the plasma following intraperitoneal injections. Amino Acids 26: 111–116.
Laube B, Langosch D, Betz H, Schmieden V. 1995. Hyperekplexia mutations of the glycine receptor unmask the inhibitory subsite for β-amino acids. Neuroreport 6: 897–900.
Law RO. 1989. The effect of pregnancy on the content of water, taurine, and total amino nitrogen in rat cerebral cortex. J Neurochem 53: 300–302.
Law RO. 1994. Effects of extracellular bicarbonate ions and pH on volume-regulatory taurine efflux from rat cerebral cortical slices in vitro: Evidence for separate neutral and anionic transport mechanisms. Biochim Biophys Acta 1224: 377–383.
Law RO. 1995. Taurine efflux and cell volume regulation in cerebral cortical slices during chronic hypernatraemia. Neurosci Lett 185: 56–59.
Law RO. 2006. The mechanisms of taurine's protective action against acute guanidino neurotoxicity. Taurine 6. Oja SS, Saransaari P, editors. New York: Springer/Kluwer Academic; pp. 359–364.
Lee CM, Tung WL, Young JD. 1992. Tachykinin-stimulated inositol phospholipid hydrolysis and taurine release from human astrocytoma cells. J Neurochem 59: 406–414.
Lee NY, Kang YS. 2004. The brain-to-blood efflux transport of taurine and changes in the blood-brain barrier transport system by tumor necrosis factor-α. Brain Res 1023: 141–147.
Lehmann A. 1987. Pentylenetetrazol seizure threshold and extracellular levels of cortical amino acids in taurine-deficient kittens. Acta Physiol Scand 131: 453–458.
Lehmann A. 1989. Effects of microdialysis-perfusion with anisosmotic media on extracellular amino acids in the rat hippocampus and skeletal muscle. J Neurochem 53: 525–535.
Lehmann A, Hagberg. H, Hamberger A. 1984. A role for taurine in the maintenance of homeostasis in the central nervous system during hyperexcitation? Neurosci Lett 52: 341–346.
Lehmann A, Huxtable RJ, Hamberger A. 1987. Taurine deficiency in the rat and cat: Effects on neurotoxic and biochemical actions of kainate. Adv Exp Med Biol 213: 331–339.
Lekieffre D, Callebert J, Plotkine M, Boulu RG. 1992. Concomitant increases in the extracellular concentrations of excitatory and inhibitory amino acids in the rat hippocampus during forebrain ischemia. Neurosci Lett 137: 78–82.
Lerma J, Herranz AS, Herreras O, Abraira V, MartÃn del RÃo R. 1986. In vivo determination of extracellular concentration of amino acids in the rat hippocampus. A method based on brain dialysis and computerized analysis. Brain Res 384: 145–155.
Leviel V, Chéramy A, Nieoullon A, Glowinski J. 1979. Symmetric bilateral changes in dopamine release from the caudate nuclei of the cat induced by unilateral nigral application of glycine and GABA-related compounds. Brain Res 175: 259–270.
Levinskaya N, Trenkner E, El Idrissi A. 2006. Increased GAD-positive neurons in the cortex of taurine-fed mice. Taurine 6. Oja SS, Saransaari P, editors. New York: Springer/Kluwer Academic; pp. 411–417.
Lewin L, Rassin DK, Sellström Å. 1994. Net taurine transport and its inhibition by a taurine antagonist. Neurochem Res 19: 347–352.
Li G, Liu Y, Olson JE. 2002. Calcium/calmodulin-modulated chloride and taurine conductances in cultured rat astrocytes. Brain Res 925: 1–8.
Li H, Godfrey DA, Rubin AM. 1994. Quantitative distribution of amino acids in the rat vestibular nuclei. J Vest Res 4: 437–452.
Li H, Godfrey TG, Godfrey DA, Rubin AM. 1996. Quantitative changes of amino acid distributions in the rat vestibular nuclear complex after unilateral vestibular ganglionectomy. J Neurochem 66: 1550–1564.
Li YP, Lombardini JB. 1991. Inhibition by taurine of the phosphorylation of specific synaptosomal proteins in the rat cortex: Effects of taurine on the stimulation of calcium uptake in mitochondria and inhibition of phosphoinositide turnover. Brain Res 553: 89–96.
Li ZP, Zhang XY, Lu X, Zhong MK, Ji YH. 2004. Dynamic release of amino acid transmitters induced by valproate in PTZ-kindled epileptic rat hippocampus. Neurochem Int 44: 264–270.
Li ZQ, Yamamoto Y, Morimoto T, Ono J, Okada S, et al. 2000. The effect of pentylenetetrazole-kindling on the extracellular glutamate and taurine levels in the frontal cortex of rats. Neurosci Lett 282: 117–119.
Liebowitz SM, Lombardini JB, Allen IA. 1986. 2-Aminoethymethy-sulfone (AEMS): A potent stimulator of ATP-dependent calcium uptake. Eur J Pharmacol 120: 111-113.
Liebowitz SM, Lombardini JB, Allen CI. 1988. Effects of aminocycloalkanesulfonic acid analogs of taurine on ATP-dependent calcium ion uptake and protein phosphorylation. Biochem Pharmacol 37: 1303–1309.
Liebowitz SM, Lombardini JB, Allen CI. 1989. Sulfone analogues of taurine as modifiers of calcium uptake and protein phosphorylation in rat retina. Biochem Pharmacol 38: 399–406.
Liebowitz SM, Lombardini JB, Salva PS. 1987. Cyclic taurine analogs. Synthesis and effects on ATP-dependent Ca2+ uptake in rat retina. Biochem Pharmacol 36: 2109–2114.
Lien YH, Shapiro JI, Chan L. 1991. Study of brain electrolytes and organic osmolytes during correction of chronic hyponatremia. Implications for the pathogenesis of central pontine myelinolysis. J Clin Invest 88: 303–309.
Lima L. 1999. Taurine and its trophic effects in the retina. Neurochem Res 24: 1333–1338.
Lima L, Cubillos S. 1998a. Taurine might be acting as a trophic factor in the retina by modulating phosphorylation of cellular proteins. J Neurosci Res 53: 377–384.
Lima L, Cubillos S. 1998b. Taurine-stimulated outgrowth from the retina is impaired by protein kinase C activators and phosphatase inhibitors. Adv Exp Med Biol 442: 423–430.
Lima L, Cubillos S, Fazzino F. 2003. Taurine effect on neuritic outgrowth from goldfish retinal explants in the absence and presence of fetal calf serum. Adv Exp Med Biol 526: 507–514.
Lima L, Cubillos S, Guerra A. 2000. Regulation of high affinity taurine transport in goldfish and rat retinal cells. Adv Exp Med Biol 483: 431–440.
Lima L, Drujan B, Matus P. 1990. Spatial distribution of taurine in the teleost retina and its role in retinal tissue regeneration. Prog Clin Biol Res 351: 103–112.
Lima L, Matus P, Drujan B. 1988. Taurine effect on neuritic growth from goldfish retinal explants. Int J Dev Neurosci 6: 417–424.
Lima L, Matus P, Drujan B. 1989. The interaction of substrate and taurine modulates the outgrowth from regenerating goldfish retinal explants. Int J Dev Neurosci 7: 375–382.
Lima L, Matus P, Drujan B. 1991. Differential taurine uptake in central and peripheral regions of goldfish retina. J Neurosci Res 28: 422–427.
Lima L, Matus P, Drujan B. 1992. The trophic role of taurine in the retina. A possible mechanism of action. Adv Exp Med Biol 315: 287–294.
Lima L, Matus P, Drujan B. 1993. Taurine-induced regeneration of goldfish retina in culture may involve a calcium-mediated mechanism. J Neurochem 60: 2153–2158.
Lima L, Obregón F, Cubillos S, Fazzino F, Jaimes I. 2001. Taurine as micronutrient in development and regeneration of the central nervous system. Nutr Neurosci 4: 439–443.
Lima L, Obregón F, Matus P. 1998. Taurine, glutamate and GABA modulate the outgrowth from goldfish retinal explants and its concentrations are affected by the crush of the optic nerve. Amino Acids 15: 195–209.
Lima L, Roussó T, Quintal M, Benzo Z, Auladell C. 2004. Content and concentration of taurine, hypotaurine, and zinc in the retina, the hippocampus, and the dentate gyrus of the rat at various postnatal days. Neurochem Res 29: 247–255.
Lindén IB, Gothóni G, Kontro P, Oja SS. 1983. Anticonvulsant activity of 2-phthalimidoethanesulfonamides: New derivatives of taurine. Neurochem Int 5: 319–324.
Linne ML, Jalonen TO, Saransaari P, Oja SS. 1996. Taurine-induced single-channel currents in cultured rat cerebellar granule cells. Adv Exp Med Biol 403: 455–462.
Liu G, Liu Y, Olson JE. 2002. Calcium/calmodulin-modulated chloride and taurine conductances in cultured rat astrocytes. Brain Res 925: 1–8.
Liu QR, López-Corcuera B, Mandiyan S, Nelson H, Nelson N. 1993. Molecular characterization of four pharmacologically distinct γ-aminobutyric acid transporters in mouse brain. J Biol Chem 268: 2106–2112.
Liu QR, López-Corcuera B, Nelson H, Mandiyan S, Nelson N. 1992. Cloning and expression of cDNA encoding the transporter of taurine and β-alanine in mouse brain. Proc Natl Acad Sci USA 89: 12145–12149.
Lo EH, Pierce AR, Matsumoto K, Kano T, Evans CJ, et al. 1998. Alterations in K+ evoked profiles of neurotransmitter and neuromodulator amino acids after focal ischemia-reperfusion. Neuroscience 83: 449–458.
Lombardini JB. 1988. Effects of taurine and mitochondrial metabolic inhibitors on ATP-dependent Ca2+ uptake in synaptosomal and mitochondrial subcellular fractions of rat retina. J Neurochem 51: 200–205.
Lombardini JB. 1991. Taurine: Retinal function. Brain Res Rev 16: 151–169.
Lombardini JB. 1992a. Effects of taurine on the phosphorylation of specific proteins in subcellular fractions of the rat retina. Neurochem Res 17: 821–824.
Lombardini JB. 1992b. Potassium-stimulated release of taurine in a crude retinal preparation obtained from the rat is calcium independent. Adv Med Exp Biol 315: 399–404.
Lombardini JB. 1993a. Spontaneous and evoked release of [3H]taurine from a P2 subcellular fraction of the rat retina. Neurochem Res 18: 193–202.
Lombardini JB. 1993b. Partial characterization of an approximately 20 K M r retinal protein whose phosphorylation is inhibited by taurine. Biochem Pharmacol 46: 1445–1451.
Lombardini JB. 1998. Increased phosphorylation of specific rat cardiac and retinal proteins in taurine-depleted animals: Isolation and identification of the phosphoproteins. Adv Exp Med Biol 442: 441–447.
Lombardini JB, Liebowitz SM. 1990a. Inhibitory and stimulatory effects of structural and conformational analogues of taurine on ATP-dependent calcium ion uptake in the rat retina: Deductions concerning the conformation of taurine. Prog Clin Biol Res 351: 197–206.
Lombardini JB, Liebowitz SM. 1990b. Taurine analogues as modifiers of the accumulation of 45calcium ions in a rat retinal membrane preparation. Curr Eye Res 9: 1147–1156.
Lombardini JB, Props C. 1996. Effects of kinase inhibitors and taurine analogues on the phosphorylation of specific proteins in mitochondrial fractions of rat heart and retina. Adv Exp Med Biol 403: 343–350.
Lombardini JB, Liebowitz SM, Chou TC. 1989. Analogues of taurine as stimulators and inhibitors of ATP-dependent calcium ion uptake in rat retina: Combination kinetics. Mol Pharmacol 36: 256-264.
Loo DDF, Hirsch JR, Sarkar HK, Wright EM. 1996. Regulation of the mouse retinal taurine transporter (TAUT) by protein kinases in Xenopus oocytes. FEBS Lett 392: 250–254.
Louzada PR, Lima ACP, Mendonça-Silva DL, Noël F, De Mello FG, et al. 2004. Taurine prevents the neurotoxicity of β-amyloid and glutamate receptor agonists: Activation of GABA receptors and possible implications for Alzheimer's disease and other neurological disorders. FASEB J 18: 511–518.
Lu P, Xu W, Sturman JA. 1996. Dietary β-alanine results in taurine depletion and cerebellar damage in adult cats. J Neurosci Res 43: 112–119.
Lucchi R, Poli A, Traversa U, Barnabei O. 1994. Functional adenosine A1 receptors in goldfish brain: Regional distribution and inhibition of K+-evoked glutamate release from cerebellar slices. Neuroscience 58: 237–243.
Lynch JW, Rajendra S, Pierce KD, Handford CA, Barry PH, et al. 1997. Identification of intracellular and extracellular domains mediating signal transduction in the inhibitory glycine receptor chloride channel. EMBO J 16: 110–120.
Maar T, Morán J, Schousboe A, Pasantes-Morales H. 1995. Taurine deficiency in dissociated mouse cerebellar neurons affects neuronal migration. Int J Dev Neurosci 13: 491–502.
Madelian V, Silliman S, Shain W. 1988. Adenosine stimulates cAMP-mediated taurine release from LRM55 glial cells. J Neurosci Res 20: 176–181.
Magnusson KR, Koerner JF, Larson AA, Smullin DH, Skilling SR, et al. 1991. NMDA-, kainate- and quisqualate-stimulated release of taurine from electrophysiologically monitored rat hippocampal slices. Brain Res 549: 1–8.
Malcangio M, Bartolini A, Ghelardini C, Bennardini F, Malmberg-Aiello P, et al. 1989. Effects of ICV taurine on the impairment of learning, convulsions and death caused by hypoxia. Psychopharmacology 98: 316–320.
Malminen O, Kontro P. 1986. Modulation of the GABA-benzodiazepine receptor complex by taurine in rat brain membranes. Neurochem Res 11: 85–94.
Malminen O, Kontro P. 1987. Actions of taurine on the GABA-benzodiazepine receptor complex solubilized from rat brain. Neurochem Int 11: 113–117.
Mandel P, Gupta RC, Bourguignon JJ, Wermuth CG, Molina V, et al. 1985. Effects of taurine and taurine analogues on aggressive behavior. Prog Clin Biol Res 179: 449–458.
Mankovskaya IN, Serebrovskaya TV, Swanson RJ, Vavilova GL, Kharlamova ON. 2000. Mechanisms of taurine antihypoxic and antioxidant action. High Alt Med Biol 1: 105–110.
Marangolo M, Zisterer D, Williams DC, Tipton KF, Della Corte L. 1997. Different specificities for taurine analogues and their target sites in brain. Neurochemistry: Cellular, Molecular and Clinical Aspects. Teelken A, Korf J, editors. New York: Plenum Press; pp. 59–962.
Marc RE, Murry RF, Fisher SK, Linberg KA, Lewis GP, et al. 1998. Amino acid signatures in the normal cat retina. Invest Ophthalmol Vis Sci 39: 1685–1693.
Marnela K-M, Kontro P. 1984. Free amino acids and the uptake and binding of taurine in the central nervous system of rats treated with guanidinoethanesulphonate. Neuroscience 12: 323–328.
Marnela K-M, Morris HR, Panico M, Timonen M, Lähdesmäki P. 1985. Glutamyl-taurine is the predominant synaptic peptide. J Neurochem 44: 752–754.
Marnela K-M, Timonen M, Lähdesmäki P. 1984. Mass spectrometric analyses of brain synaptic peptides containing taurine. J Neurochem 43: 1650–1653.
Martin DL, Madelian V, Seligman B, Shain W. 1990. The role of osmotic pressure and membrane potential in K+-stimulated taurine release from cultured astrocytes and LRM55 cells. J Neurosci 10: 571–577.
MartÃnez A, Muñoz-Clares RA, Guerra G, Morán J, Pasantes-Morales H. 1994. Sulfhydryl groups essential for the volume-sensitive release of taurine from astrocytes. Neurosci Lett 176: 239–242.
Matsuda T, Takuma K, Kishida Y, Azuma J, Baba A. 1996. Protective effect of taurine against reperfusion injury in cultured rat astrocytes. Adv Exp Med Biol 403: 491–497.
Matsumoto K, Lo EH, Pierce AR, Halpern EF, Newcomb R. 1996. Secondary elevation of extracellular neurotransmitter amino acids in the reperfusion phase following focal cerebral ischemia. J Cereb Blood Flow Metab 16: 114–124.
Matus P, Cubillos S, Lima L. 1997. Differential effect of taurine and serotonin on the outgrowth from explants or isolated cells of the retina. Int J Dev Neurosci 15: 785–793.
McBroom MJ, Elkhawad AO, Dlouha H. 1986. Taurine and ethanol-induced sleeping time in mice: Route and time course effects. Gen Pharmacol 17: 97–100.
McCabe BJ, Horn G. 1988. Learning and memory: Regional changes in N-methyl-d-aspartate receptors in the chick brain after imprinting. Proc Natl Acad Sci USA 85: 2849–2853.
McCabe BJ, Horn G, Kendrick KM. 2001. GABA, taurine and learning: Release of amino acids from slices of chick brain following filial imprinting. Neuroscience 105: 317–324.
McCaslin PP, Yu XZ. 1992. Cyanide selectively augments kainate—but not NMDA—induced release of glutamate and taurine. Eur J Pharmacol 228: 73–75.
McCaslin PP, Yu XZ, Ho IK, Smith TG. 1992. Amitriptyline prevents N-methyl-d-aspartate (NMDA)-induced toxicity, does not prevent NMDA-induced elevations of extracellular glutamate, but augments kainate-induced elevations of glutamate. J Neurochem 59: 401–405.
McCool BA, Botting SK. 2000. Characterization of strychnine-sensitive glycine receptors in acutely isolated adult rat basolateral amygdala neurons. Brain Res 859: 341–351.
Medina JH, De Robertis E. 1984. Taurine modulation of the benzodiazepine-γ-aminobutyric acid receptor complex in brain membranes. J Neurochem 42: 1212–1217.
Mehta TR, Dawson R Jr. 2001. Taurine is a weak scavenger of peroxynitrite and does not attenuate sodium nitroprusside toxicity to cells in culture. Amino Acids 20: 419–433.
Melamed N, Kanner BI. 2004. Transmembrane domains I and II of the γ-aminobutyric acid transporter GAT-4 contain molecular determinants of substrate specificity. Mol Pharmacol 65: 1452–1461.
Mellor RJ, Gunthorpe MJ, Randall AD. 2000. The taurine uptake inhibitor guanidinoethyl sulphonate is an agonist at γ-aminobutyric acidA receptors in cultured murine cerebellar granule cells. Neurosci Lett 286: 25–28.
Menéndez N, SolÃs JM, Herreras O, Galarreta M, Conejero C, et al. 1993. Taurine release evoked by NMDA receptor activation is largely dependent on calcium mobilization from intracellular stores. Eur J Neurosci 5: 1273–1279.
Menéndez N, SolÃs JM, Herreras O, Herranz AS, MartÃn del RÃo R. 1990. Role of endogenous taurine on the glutamate analogue-induced neurotoxicity in the rat hippocampus in vivo. J Neurochem 55: 714–717.
Meredith RM, McCabe BJ, Kendrick KM, Horn G. 2004. Amino acid neurotransmitter release and learning: A study of visual imprinting. Neuroscience 126: 249–256.
Mialon P, Joanny P, Gibey R, Cann-Moisan C, Caroff J, et al. 1995. Amino acids and ammonia in the cerebral cortex, the corpus striatum and the brain stem of the mouse prior to the onset and after a seizure induced by hyperbaric oxygen. Brain Res 676: 352–357.
Miele M, Berners M, Boutelle MG, Kusakabe H, Fillenz M. 1996. The determination of the extracellular concentration of brain glutamate using quantitative microdialysis. Brain Res 707: 131–133.
Militante JD, Lombardini JB. 1998a. Effect of taurine on chelerythrine inhibition of calcium uptake and ATPase activity in the rat retina. Biochem Pharmacol 55: 557–565.
Militante JD, Lombardini JB. 1998b. Pharmacological characterization of the effects of taurine on calcium uptake in the rat retina. Amino Acids 15: 99–108.
Militante JD, Lombardini JB. 1999a. Taurine uptake activity in the rat retina: Protein kinase C-independent inhibition by chelerythrine. Brain Res 818: 368–374.
Militante JD, Lombardini JB. 1999b. Stimulatory effect of taurine on calcium ion uptake in rod outer segments of the rat retina is independent of taurine uptake. J Pharmacol Exp Ther 291: 383–389.
Militante JD, Lombardini JB. 2000a. Stabilization of calcium uptake in rat outer rod segments by taurine and ATP. Amino Acids 19: 561–570.
Militante JD, Lombardini JB. 2000b. Characterization of taurine uptake in the rat retina. Adv Exp Med Biol 483: 461–467.
Militante JD, Lombardini JB. 2002. Taurine: Evidence of physiological function in the retina. Nutr Neurosci 5: 75–90.
Militante JD, Lombardini JB. 2003a. Taurine stimulation of calcium uptake in the retina. Adv Exp Med Biol 526: 547–554.
Militante JD, Lombardini JB. 2003b. The nature of taurine binding in the retina. Adv Exp Med Biol 526: 555–560.
Miller TJ, Hanson RD, Yancey PH. 2000. Developmental changes in organic osmolytes in prenatal and postnatal rat tissues. Comp Biochem Physiol A Mol Integr Physiol 125: 45–56.
Miyamoto KJ, Miyamoto MR, Miyamoto TA. 2006. Systemically administered taurine. Taurine 6. Oja SS, Saransaari P, editors. New York: Springer/Kluwer Academic; pp. 323–351.
Miyamoto TA, Miyamoto KJ. 1999. Does adenosine release taurine in the A1-receptor-rich hippocampus? J Anesth 13: 94–98.
Miyamoto Y, Marczin N, Catravas JD, Del Monte MA. 1996a. Cholera toxin enhances taurine uptake in cultures of human retinal pigment epithelial cells. Curr Eye Res 15: 229–236.
Miyamoto Y, Liou GI, Sprinkle TJ. 1996b. Isolation of a cDNA encoding a taurine transporter in the human retinal pigment epithelium. Curr Eye Res 15: 345–349.
Miyata S, Matsushima O, Hatton GI. 1997. Taurine in rat posterior pituitary: Localization in astrocytes and selective release by hypoosmotic stimulation. J Comp Neurol 381: 513–523.
Molchanova S, Kööbi P, Oja SS, Saransaari P. 2004a. Interstitial concentrations of amino acids during global forebrain ischemia and potassium-evoked spreading depression. Neurochem Res 29: 1519–1527.
Molchanova S, Oja SS, Saransaari P. 2004b. Characteristics of basal taurine release in the rat striatum measured by microdialysis. Amino Acids 27: 261–268.
Molchanova SM, Oja SS, Saransaari P. 2005. Mechanisms of enhanced taurine release under Ca2+ depletion. Neurochem Int 47: 343–349.
Molchanova SM, Oja SS, Saransaari P. 2006. Properties of basal taurine release in the rat striatum in vivo. Taurine 6. Oja SS, Saransaari P, editors. New York: Springer/Kluwer Academic; pp. 365–375.
Molineux H, Schofield R, Testa NG. 1987. Hematopoietic effects of TCNU in mice. Cancer Treat Rep 71: 837–841.
Morán J, Hernández-Pech X, Merchant-Larios H, Pasantes-Morales H. 2000. Release of taurine in apoptotic cerebellar granule neurons in culture. Pflügers Arch 439: 271–277.
Mori M, Gähwiler BH, Gerber U. 2002. β-Alanine and taurine as endogenous agonists at glycine receptors in rat hippocampus in vitro. J Physiol 539: 191–200.
Nabekura J, Omura T, Akaike N. 1996a. α2 adrenoceptor potentiates glycine receptor-mediated taurine response through protein kinase A in rat substantia nigra neurons. J Neurophysiol 76: 2447–2454.
Nabekura J, Omura T, Horimoto N, Ogawa T, Akaike N. 1996b. α1 adrenoceptor activation potentiates taurine response through protein kinase C in rat substantia nigra neurons. J Neurophysiol 76: 2455–2460.
Nagelhuis EA, Amiry-Moghaddam M, Lehmann A, Ottersen OP. 1994. Taurine as an organic osmolyte in the intact brain: Immunocytochemical and biochemical studies. Adv Exp Med Biol 359: 325–334.
Nagelhuis EA, Lehmann A, Ottersen OP. 1993. Neuronal-glial exchange of taurine during hypo-osmotic stress: A combined immunocytochemical and biochemical analysis in rat cerebellar cortex. Neuroscience 54: 615–631.
Nakamori K, Koyama I, Nakamura T, Nemoto M, Yoshida T, et al. 1993. Quantitative evaluation of the effectiveness of taurine in protecting the ocular surface against oxidant. Chem Pharm Bull 41: 335–338.
Nakane H, Yao H, Ibayashi S, Kitazono T, Ooboshi H, et al. 1998. Protein kinase C modulates ischemia-induced amino acids release in the striatum of hypertensive rats. Brain Res 782: 290–296.
Neuringer M, Sturman JA, Wen GY, Wisniewski HM. 1985. Dietary taurine is necessary for normal retinal development in monkeys. Prog Clin Biol Res 179: 53–62.
Nilsson GE, Lutz PL. 1991. Release of inhibitory neurotransmitters in response to anoxia in turtle brain. Am J Physiol 261: R32–R37.
Nusetti S, Obregón F, Lima L. 2006. Neuritic outgrowth from goldfish retinal explants, interaction of taurine and zinc. Taurine 6. Oja SS, Saransaari P, editors. New York: Springer/Kluwer Academic; pp. 435–440.
Nusetti S, Obregón F, Quintal M, Benzo Z, Lima L. 2005. Taurine and zinc modulate outgrowth from goldfish retinal explants. Neurochem Res 30: 1483–1492.
O'Byrne MB, Tipton KF. 2000. Taurine-induced attenuation of MPP+ neurotoxicity in vitro: A possible role for the GABAA subclass of GABA receptors. J Neurochem 74: 2087–2093.
Oja SS, Kontro P. 1981. Oxidation of hypotaurine in vitro by mouse liver and brain tissues. Biochim Biophys Acta 677: 350–357.
Oja SS, Kontro P. 1983a. Taurine. Handbook of Neurochemistry, Vol. 3. Lajtha A, editor. 2nd edn, New York: Plenum Press; pp. 501–533.
Oja SS, Kontro P. 1983b. Free amino acids in epilepsy: Possible role of taurine. Acta Neurol Scand 67 (Suppl. 93): 5–20.
Oja SS, Saransaari P. 1992a. Cell volume changes and taurine release in cerebral cortical slices. Adv Exp Med Biol 315: 369–374.
Oja SS, Saransaari P. 1992b. Taurine release and swelling of cerebral cortex slices from adult and developing mice in media of different ionic compositions. J Neurosci Res 32: 551–561.
Oja SS, Saransaari P. 1995. Chloride ions, potassium stimulation and release of endogenous taurine from cerebral cortical slices from 3-day-old and 3-month-old mice. Neurochem Int 27: 313–318.
Oja SS, Saransaari P. 1996a. Taurine as osmoregulator and neuromodulator in the brain. Metab Brain Dis 11: 153–164.
Oja SS, Saransaari P. 1996b. Kinetic analysis of taurine influx into cerebral cortical slices from adult and developing mice in different incubation conditions. Neurochem Res 21: 161–166.
Oja SS, Saransaari P. 2000. Modulation of taurine release by glutamate receptors and nitric oxide. Prog Neurobiol 62: 407–425.
Oja SS, Saransaari P, editors. 2006. Taurine 6. New York: Springer/Kluwer Academic.
Oja SS, Holopainen I, Kontro P. 1990a. Stimulated taurine release from different brain preparations: Changes during development and aging. Prog Clin Biol Res 351: 277–287.
Oja SS, Korpi ER, Saransaari P. 1990b. Modification of chloride flux across brain membranes by inhibitory amino acids in developing and adult mice. Neurochem Res 15: 797–804.
Oja SS, Kontro P, Lähdesmäki P. 1977. Amino acids as inhibitory neurotransmitters. Prog Pharmacol 1/3: 1–119.
Oja SS, Kontro P, Lindén IB, Gothóni G. 1983. Anticonvulsant action of some 2-aminoethanesulfonic acid (taurine) derivatives. Eur J Pharmacol 87: 191–198.
Oja SS, Lehtinen I, Lähdesmäki P. 1976. Taurine transport rates between plasma and tissues in adult and 7-day-old mice. Q J Exp Physiol 61: 133–143.
Oja SS, Uusitalo AJ, Vahvelainen ML, Piha RS. 1968. Changes in cerebral and hepatic amino acids in the rat and guinea pig during development. Brain Res 11: 655–661.
Okamoto K, Kimura H, Sakai Y. 1983a. Taurine-induced increase of the Cl− conductance of cerebellar Purkinje cell dendrites in vitro. Brain Res 259: 319–323.
Okamoto K, Kimura H, Sakai Y. 1983b. Evidence for taurine as an inhibitory neurotransmitter in cerebellar stellate interneurons: Selective antagonism by TAG (6-aminomethyl-4H1,2,4-benzothiadiazine-1,1-dioxide). Brain Res 265: 163–168.
Okamoto K, Kimura H, Sakai Y. 1983c. Antagonistic action of 6-aminomethyl-4H1,2,4-benzothiadiazine-1,1-dioxide (TAG), and evidence for a transmitter role of taurine in stellate interneurons in the cerebellum. Prog Clin Biol Res 125: 151–160.
Olive MF. 2002. Interactions between taurine and ethanol in the central nervous system. Amino Acids 23: 345–357.
Olive MF, Mehmert KK, Hodge CW. 2000a. Modulation of extracellular neurotransmitter levels in the nucleus accumbens by a taurine uptake inhibitor. Eur J Pharmacol 409: 291–294.
Olive MF, Mehmert KM, Messing RO, Hodge CW. 2000b. Reduced operant ethanol self-administration and in vivo mesolimbic dopamine responses to ethanol in PKCɛ deficient mice. Eur J Neurosci 12: 4131–4140.
Olive MF, Nannini MA, Ou CJ, Koenig HN, Hodge CW. 2002. Effects of acute acamprosate and homotaurine on ethanol intake and ethanol-stimulated mesolimbic dopamine release. Eur J Pharmacol 437: 55–61.
Olson JE, Goldfinger MD. 1990. Amino acid content of rat cerebral astrocytes adapted to hyperosmotic medium in vitro. J Neurosci Res 27: 241–246.
Olson JE, Martinho E Jr. 2006. Taurine transporter regulation in hippocampal neurons. Taurine 6. Oja SS, Saransaari P, editors. New York: Springer/Kluwer Academic; pp. 307–314.
Olson JE, Banks M, Dimlich RV, Evers J. 1997. Blood-brain barrier water permeability and brain osmolyte content during edema development. Acad Emerg Med 4: 662–673.
Olson JE, Evers JA, Banks M. 1994. Brain osmolyte content and blood-brain barrier water permeability surface area product in osmotic edema. Acta Neurochir (Suppl.) 60: 571–573.
O'Neill R. 1986. Effects of intranigral injection of taurine and GABA on striatal dopamine release monitored voltammetrically in the unanaesthetized rat. Brain Res 382: 28–32.
Ooboshi H, Sadoshima S, Yao H, Ibayashi S, Matsumoto T, et al. 1995. Ischemia-induced release of amino acids in the hippocampus of aged hypertensive rats. J Cereb Blood Flow Metab 15: 227–234.
O'Regan MH, Smith-Barbour M, Perkins LM, Phillis JW. 1995. A possible role of phospholipases in the release of transmitter amino acids from ischemic rat cerebral cortex. Neurosci Lett 185: 191–194.
Palmi M, Frosini M, Sgaragli GP. 1987. Possible involvement of brain calcium metabolism in the action of taurine in mammalian thermoregulation. Adv Exp Med Biol 217: 237–244.
Pasantes-Morales H, Cruz C. 1985. Taurine and hypotaurine inhibit light-induced lipid peroxidation and protect rod outer segment structure. Brain Res 330: 154–157.
Pasantes-Morales H, Franco R. 2002. Influence of protein tyrosine kinases and cell volume change-induced taurine release. Cerebellum 1: 103–109.
Pasantes-Morales H, Schousboe A. 1988. Volume regulation in astrocytes: A role of taurine as an osmoeffector. J Neurosci Res 20: 505–509.
Pasantes-Morales H, Schousboe A. 1989. Release of taurine from astrocytes during potassium-evoked swelling. Glia 2: 45–50.
Pasantes-Morales H, Schousboe A. 1997. Role of taurine in osmoregulation in brain cells: Mechanisms and functional implications. Amino Acids 12: 281–292.
Pasantes-Morales H, Arzate ME, Quesada O, Huxtable RJ. 1987. Higher susceptibility of taurine-deficient rats to seizures induced by 4-aminopyridine. Neuropharmacology, 26: 1721–1725.
Pasantes-Morales H, Cardin V, Tuz K. 2000a. Signaling events during swelling and regulatory volume decrease. Neurochem Res 25: 1301–1314.
Pasantes-Morales H, Franco R, Torres-Marquez ME, Hernandez-Fonseca K, Ortega A. 2000b. Amino acid osmolytes in regulatory volume decrease and isovolumetric regulation in brain cells: Contribution and mechanisms. Cell Physiol Biochem 10: 361–370.
Pasantes-Morales H, Franco R, Ochoa L, Ordaz B. 2002a. Osmosensitive release of neurotransmitter amino acids: Relevance and mechanisms. Neurochem Res 27: 59–65.
Pasantes-Morales H, Franco R, Ordaz B, Ochoa LD. 2002b. Mechanisms counteracting swelling in brain cells during hyponatremia. Arch Med Res 33: 237–244.
Pasantes-Morales H, Moran J, Schousboe A. 1990. Volume-sensitive release of taurine from cultured astrocytes: Properties and mechanism. Glia 4: 427–432.
Pazdernik TL, Wade JV, Nelson SR, Samson FE. 1990. Is taurine involved in cerebral osmoregulation? Adv Exp Med Biol 403: 117–124.
Pérez-Pinzón MA, Nilsson GE, Lutz PL. 1993. Relationship between ion gradients and neurotransmitter release in the newborn rat striatum during anoxia. Brain Res 602: 228–233.
Petrosian AM, Haroutounian JE. 1990. Tauret: Further studies on the role of taurine in retina. Prog Clin Biol Res 351: 471–475.
Petrosian AM, Haroutounian JE. 1998. The role of taurine in osmotic, mechanical, and chemical protection of the retinal outer segments. Adv Exp Med Biol 442: 407–413.
Petrosian AM, Haroutounian JE. 2000. Taurine as a universal carrier of lipid soluble vitamins: A hypothesis. Amino Acids 19: 409–421.
Petrosian AM, Haroutounian JE, Fugelli K, Kanli H. 2000a. Effects of osmotic and light stimulation on 3H-taurine efflux from isolated rod outer segments and synthesis of tauret in the frog retina. Adv Exp Med Biol 483: 441–451.
Petrosian AM, Haroutounian JE, Gundersen TE, Blomhoff R, Fugelli K, et al. 2000b. New HPLC evidence on endogenous tauret in retina and pigment epithelium. Adv Exp Med Biol 483: 453–460.
Petrosian AM, Haroutounian JE, Zueva LV. 1996. Tauret: A taurine-related endogenous substance in the retina and its role in vision. Adv Exp Med Biol 403: 333–342.
Phillis JW, Ren J, O'Regan MH. 2000. Transporter reversal as a mechanism of glutamate release from the ischemic rat cerebral cortex: Studies with dl-threo-β-benzyloxyaspartate. Brain Res 868: 105–112.
Phillis JW, Song D, O'Regan MH. 1996. Inhibition of tyrosine phosphorylation attenuates amino acid neurotransmitter release from the ischemic/reperfused rat cerebral cortex. Neurosci Lett 207: 151–154.
Phillis JW, Song D, O'Regan MH. 1997. Inhibition of anion channel blockers of ischemia-evoked release of excitotoxic and other amino acids from rat cerebral cortex. Brain Res 758: 9–16.
Phillis JW, Song D, O'Regan MH. 1998. Tamoxifen, a chloride channel blocker, reduces glutamate and aspartate release from the ischemic cerebral cortex. Brain Res 780: 352–355.
Phillis JW, Song D, O'Regan MH. 1999. Effects of hyperosmolarity and ion substitutions on amino acid efflux from the ischemic rat cerebral cortex. Brain Res 828: 1–11.
Pow DV. 1993. Immunocytochemistry of amino-acids in the rodent pituitary using extremely specific, very high titre antisera. J Neuroendoc 5: 349–356.
Pow DV, Sullivan R, Reye P, Hermanussen S. 2002. Localization of taurine transporters, taurine and 3H taurine accumulation in the rat retina, pituitary, and brain. Glia 37: 153–168.
Puka M, Lehmann A. 1994. In vivo acidosis reduces extracellular concentrations of taurine and glutamate in the rat hippocampus. J Neurosci Res 37: 641–646.
Puka M, Albrecht J, Lazarewicz JW. 1992. Noradrenaline- and glutamate-induced taurine release from bulk isolated adult rat astrocytes. Acta Neurobiol Exp 52: 31–35.
Puopolo M, Kratskin I, Belluzzi O. 1998. Direct inhibitory effect of taurine on relay neurons of the rat olfactory bulb. Neuroreport 9: 2319–2322.
Pushpakiran G, Mahalakshmi K, Anuradha CV. 2004. Taurine restores ethanol-induced depletion of antioxidants and attenuates oxidative stress in rat tissues. Amino Acids 27: 91–96.
Quertemont E, Grant KA. 2004. Discriminative stimulus effects of ethanol: Lack of interaction with taurine. Behav Pharmacol 15: 495–501.
Quartemont E, Dahchour A, Ward RJ, De Witte P. 1999. Ethanol induces taurine release in the amygdala: An in vivo microdialysis study. Addict Biol 4: 47–54.
Quartemont E, de Neuville J, De Witte O. 1998a. Changes in the amygdala amino acid microdialysate after conditioning with a cue associated with ethanol. Psychopharmacology 139: 71–78.
Quartemont E, Goffaux V, Vlaminck AM, Wolff C, De Witte P. 1998b. Oral taurine supplementation modulates ethanol-conditioned stimulus preference. Alcohol 16: 201–206.
Quartemont E, Devitgh A, De Witte P. 2003. Systemic osmotic manipulations modulate ethanol-induced taurine release: A brain microdialysis study. Alcohol 29: 11–19.
Quinn MR, Harris CL. 1995. Taurine allosterically inhibits binding of [35S]-t-butyl-bicyclophosphonothionate (TBPS) to rat brain synaptic membranes. Neuropharmacology 34: 1607–1613.
Quinn MR, Miller CI. 1992. Taurine allosterically modulates flunitrazepam binding to synaptic membranes. J Neurosci Res 33: 136–141.
Rainesalo S, Keränen T, Palmio J, Peltola J, Oja SS, et al. 2004. Plasma and cerebrospinal fluid amino acids in epileptic patients. Neurochem Res 29: 319–324.
Rajendra S, Lynch JW, Pierce KD, French CR, Barry PH, et al. 1995. Mutation of an arginine residue in the human glycine receptor transforms β-alanine and taurine from agonists into competitive antagonists. Neuron 14: 169–175.
Ramamoorthy D, Del Monte MA, Leibach FH, Ganapathy V. 1994. Molecular identity and calmodulin-mediated regulation of the taurine transporter in a human retinal pigment epithelial cell line. Curr Eye Res 13: 523–529.
Ramanathan VK, Chung SJ, Giacomini KM, Brett CM. 1997. Taurine transport in cultured choroid plexus. Pharm Res 14: 406–409.
Rao VLR, Audet RM, Butterworth RF. 1995. Selective alterations of extracellular brain amino acids in relation to function in experimental portal-systemic encephalopathy: Results of an in vivo microdialysis study. J Neurochem 65: 1221–1228.
Rebel G, Petegnief V, Lleu PL, Gupta RC, Guérin P, et al. 1994. New data on the regulation of taurine uptake in cultured nervous cells. Adv Exp Med Biol 359: 225–233.
Reichelt KL, Edminson PD, Kvamme E. 1976. The formation of peptide-amines from constituent amino acids and histamine in hypothalamic tissue. J Neurochem 26: 811–815.
Rivas-Arancibia S, Dorado-MartÃnez C, Borgonio-Pérez G, Hiriart-Urdanivia M, Verdugo-DÃaz L, et al. 2000a. Effects of taurine on ozone-induced memory deficits and lipid peroxidation levels in brains of young, mature, and old rats. Environ Res 82: 7–17.
Rivas-Arancibia S, Willing AE, Zigova T, RodrÃguez AI, Cahill DW, et al. 2000b. The effects of taurine on hNT neurons transplanted in adult rat striatum. Cell Transplant 9: 751–758.
Rivas-Arancibia S, RodrÃguez AI, Zigova T, Willing AE, Brown WD, et al. 2001. Taurine increases rat survival and reduces striatal damage caused by 3-nitropropionic acid. Int J Neurosci 108: 55–67.
RodrÃguez-MartÃnez E, Rugerio-Vargas C, RodrÃguez AI, Borgonio-Pérez G, Rivas-Arancibia S. 2004. Antioxidant effects of taurine, vitamin C, and vitamin E on oxidative damage in hippocampus caused by the administration of 3-nitropropionic acid in rats. Int J Neurosci 114: 1133–1145.
Rogers KL, Philibert RA, Dutton GR. 1991. K+-Stimulated amino acid release from cultured cerebellar neurons: Comparison of static and dynamic stimulation paradigms. Neurochem Res 16: 899–904.
Rosati AM, Traversa U, Lucchi R, Poli A. 1995. Biochemical and pharmacological evidence for the presence of A1 but not A2a adenosine receptors in the brain of the low vertebrate teleost Cerassium auratus (goldfish). Neurochem Int 26: 411–423.
Ross CD, Godfrey DA, Parli JA. 1995. Amino acid concentrations and selected enzyme activities in rat auditory, olfactory, and visual systems. Neurochem Res 20: 1483–1490.
Ross CD, Parli JA, Godfrey DA. 1989. Quantitative distribution of six amino acids in rat retinal layers. Vision Res 29: 1079–1084.
Rosso L, Peteri-Brunback B, Poujeol P, Hussy N, Mienville JM. 2004. Vasopressin-induced taurine efflux from rat pituicytes: A potential negative feedback for hormone secretion. J Physiol 554: 731–742.
Ruotsalainen M, Ahtee L. 1996. Intrastriatal taurine increases striatal extracellular dopamine in a tetrodotoxin-sensitive manner in rats. Neurosci Lett 212: 175–178.
Ruotsalainen M, Heikkilä M, Lillsunde P, Seppälä T, Ahtee L. 1996. Taurine infused intrastriatally elevates, but intranigrally decreases striatal extracellular dopamine concentration in anaesthetized rats. J Neural Transm 103: 935–946.
Ruotsalainen M, Majasaari M, Salimäki J, Ahtee L. 1998. Locally infused taurine, GABA and homotaurine alter differentially the striatal extracellular concentration of dopamine and its metabolites in rats. Amino Acids 15: 117–134.
Sakai S, Tosaka T. 1999. Analysis of hyposmolarity-induced taurine efflux pathways in the bullfrog sympathetic ganglia. Neurochem Int 34: 203–212.
Sakurai T, Miki T, Li HP, Miyatake A, Satriotomo I, et al. 2003. Colocalization of taurine and glial fibrillary acidic protein immunoreactivity in mouse hippocampus induced by short-term ethanol exposure. Brain Res 959: 160–164.
Salceda R. 1999. Insulin-stimulated taurine uptake in rat retina and retinal pigment epithelium. Neurochem Int 35: 301–306.
Salimäki J, Scriba G, Piepponen TP, Rautolahti N, Ahtee L. 2003. The effects of systemically administered taurine and N-pivaloyltaurine on striatal extracellular dopamine and taurine in freely moving rats. Naunyn Schmiedebergs Arch Pharmacol 368: 134–141.
Sánchez Olea R, Pasantes-Morales H. 1990. Chloride dependence of the K+-stimulated release of taurine from synaptosomes. Neurochem Res 15: 535–540.
Sapronov NS, Gavrovskaya LK. 2006. Taurinamide derivatives—drugs with the metabolic type of action. Taurine 6. Oja SS, Saransaari P, editors. New York: Springer/Kluwer Academic; pp. 509–514.
Saransaari P, Oja SS. 1991. Excitatory amino acids evoke taurine release from cerebral cortex slices from adult and developing mice. Neuroscience 45: 451–459.
Saransaari P, Oja SS. 1992. Release of GABA and taurine from brain slices. Prog Neurobiol 38: 455–482.
Saransaari P, Oja SS. 1993. Phencyclidine binding sites in mouse cerebral cortex during development and ageing: Effects of inhibitory amino acids. Mech Ageing Dev 68: 125–136.
Saransaari P, Oja SS. 1994. Taurine release form mouse hippocampal slices: Effects of glutamatergic substances and hypoxia. Adv Med Exp Biol 359: 279–287.
Saransaari P, Oja SS. 1996. Taurine and neural cell damage. Transport of taurine in adult and developing mice. Adv Exp Med Biol 403: 481–489.
Saransaari P, Oja SS. 1997a. Enhanced taurine release in cell-damaging conditions in the developing and ageing mouse hippocampus. Neuroscience 79: 847–854.
Saransaari P, Oja SS. 1997b. Taurine release from the developing and ageing hippocampus: Stimulation by agonists of ionotropic glutamate receptors. Mech Ageing Dev 99: 219–232.
Saransaari P, Oja SS. 1997c. Glutamate-agonist-evoked taurine release from the adult and developing mouse hippocampus in cell-damaging conditions. Amino Acids 9: 323–335.
Saransaari P, Oja SS. 1998a. Mechanisms of ischemia-induced taurine release in mouse hippocampal slices. Brain Res 807: 118–124.
Saransaari P, Oja SS. 1998b. Release of endogenous glutamate, aspartate, GABA and taurine from hippocampal slices from adult developing mice in cell-damaging conditions. Neurochem Res 23: 563–570.
Saransaari P, Oja SS. 1999a. Taurine release modified by nitric oxide-generating compounds in the developing and adult mouse hippocampus. Neuroscience 89: 1103–1111.
Saransaari P, Oja SS. 1999b. Taurine release is enhanced in cell-damaging conditions in cultured cerebral cortical astrocytes. Neurochem Res 24: 1523–1529.
Saransaari P, Oja SS. 1999c. Involvement of metabotropic glutamate receptors in taurine release in the adult and developing hippocampus. Amino Acids 16: 165–179.
Saransaari P, Oja SS. 1999d. Enhanced taurine release in cultured cerebellar granule cells in cell-damaging conditions. Amino Acids 17: 323–334.
Saransaari P, Oja SS. 1999e. Characteristics of ischemia-induced taurine release in the developing mouse hippocampus. Neuroscience 94: 949–954.
Saransaari P, Oja SS. 1999f. Anticonvulsant taurine derivatives modify taurine and GABA release in the mouse hippocampus. Proc West Pharmacol Soc 42: 27–29.
Saransaari P, Oja SS. 2000a. Taurine release modified by GABAergic agents in hippocampal slices from adult and developing mice. Amino Acids 18: 17–30.
Saransaari P, Oja SS. 2000b. Taurine and neural cell damage. Amino Acids 19: 509–526.
Saransaari P, Oja SS. 2000c. Modulation of the ischemia-induced taurine release by adenosine receptors in the developing and adult mouse hippocampus. Neuroscience 97: 425–430.
Saransaari P, Oja SS. 2002. Taurine release in the developing and adult mouse hippocampus: Involvement of cyclic guanosine monophosphate. Neurochem Res 27: 15–20.
Saransaari P, Oja SS. 2003a. Interactions of taurine and adenosine in the mouse hippocampus in normoxia and ischemia. Adv Exp Med Biol 526: 445–451.
Saransaari P, Oja SS. 2003b. Characterization of N-methyl-d-aspartate-evoked taurine release in the developing and adult mouse hippocampus. Amino Acids 24: 213–221.
Saransaari P, Oja SS. 2004. Characteristics of taurine release induced by free radicals in mouse hippocampal slices. Amino Acids 26: 91–98.
Saransaari P, Oja SS. 2006. Characteristics of taurine release in slices from adult and developing mouse brain stem. Amino Acids, in press.
Satsu H, Kobayashi Y, Yokohama T, Terasawa E, Shimizu M. 2002. Effect of dietary sulfur amino acids on the taurine content of rat tissues. Amino Acids 23: 447–452.
Schafer S, Bicker G, Ottersen OP, Storm-Mathisen J. 1988. Taurine-like immunoreactivity in the brain of the honeybee. J Comp Neurol 368: 60–70.
Schaffer SW, Azuma J, Takahashi K, Mozaffari M. 2003. Why is taurine cytoprotective? Adv Exp Med Biol 526: 307–321.
Scheller D, de Ryck M, Clincke G, Tegtmeier F. 1997. Extracellular changes of taurine in the peri-infarct zone: Effect of lubeluzole. Acta Neurochir (Suppl.) 70: 185–187.
Scheller D, Szathmary S, Kolb J, Tegtmeier F. 2000a. Observations on the relationship between the extracellular changes of taurine and glutamate during cortical spreading depression, during ischemia, and within the area surrounding a thrombotic infarct. Amino Acids 19: 571–583.
Scheller D, Korte M, Szathmary S, Tegtmeier F. 2000b. Cerebral taurine release mechanisms in vivo: Pharmacological investigation in rats using microdialysis for proof of principle. Neurochem Res 25: 801–807.
Schmieden V, Betz H. 1995. Pharmacology of the inhibitory glycine receptor: Agonist and antagonist actions of amino acids and piperidine carboxylic acid compounds. Mol Pharmacol 48: 919–927.
Schmieden V, Grenningloh G, Schofield PR, Betz H. 1989. Functional expression in Xenopus oocytes of the strychnine binding 48 kd subunit of the glycine receptor. EMBO J 8: 695–700.
Schmieden V, Kuhse J, Betz H. 1992. Agonist pharmacology of neonatal and adult glycine receptor α subunits: Identification of amino acid residues involved in taurine activation. EMBO J 11: 2025–2032.
Schousboe A, Pasantes-Morales H. 1989. Potassium-stimulated release of [3H]taurine from cultured GABAergic and glutamatergic neurons. J Neurochem 53: 1309–1315.
Schousboe A, Morán J, Pasantes-Morales H. 1990. Potassium-stimulated release of taurine from cultured cerebellar granule neurons is associated with cell swelling. J Neurosci Res 27: 71–77.
Schurr A, Rigor BM. 1987. The mechanism of neuronal resistance and adaptation to hypoxia. FEBS Lett 224: 4–8.
Schurr A, Tseng MT, West CA, Rigor BM. 1987. Taurine improves the recovery of neural function following cerebral hypoxia: An in vitro study. Life Sci 40: 2059–2066.
Segovia G, Del Arco A, Mora F. 1997. Endogenous glutamate increases extracellular concentrations of dopamine, GABA, and taurine through NMDA and AMPA/kainate receptors in striatum of the freely moving rat: A microdialysis study. J Neurochem 69: 1476–1483.
Seidl R, Peyrl A, Nicham R, Hauser E. 2000. A taurine and caffeine-containing drink stimulates cognitive performance and well-being. Amino Acids 19: 635–642.
Seki Y, Feustel PJ, Keller RW Jr, Tranmer BI, Kimelberg HK. 1999. Inhibition of ischemia-induced glutamate release in rat striatum by dihydrokainate and an anion channel blocker. Stroke 30: 433–440.
Seki Y, Kimura M, Mizutani N, Fujita M, Aimi Y, et al. 2005. Cerebrospinal fluid taurine after traumatic brain injury. Neurochem Res 30: 123–128.
Sergeeva OA, Chepkova AN, Doreulee N, Eriksson KS, Poelchen W, et al. 2003. Taurine-induced long-lasting enhancement of synaptic transmission in mice: Role of transporters. J Physiol 550: 911–919.
Sergeeva OA, Chepkova AN, Haas HL. 2002. Guanidinoethyl sulphonate is a glycine receptor antagonist in striatum. Br J Pharmacol 137: 855–860.
Serrano MI, Goicoechea C, Serrano JS, Serrano-Martino MC, Sánchez E, et al. 2002. Age-related changes in the antinociception induced by taurine in mice. Pharmacol Biochem Behav 73: 863–867.
Serrano MI, Serrano JS, Guerrero MR, Fernández A. 1994. Role of GABAA and GABAB receptors and peripheral cholinergic mechanisms in the antinociceptive action of taurine. Gen Pharmacol 24: 1123–1129.
Serrano JS, Serrano MI, Guerrero MR, Ruiz R, Polo J. 1990. Antinociceptive effect of taurine and its inhibition by naloxone. Gen Pharmacol 21: 333–336.
Sgaragli GP, Carlà V, Magnani M, Galli A. 1981. Hypothermia induced in rabbits by intracerebroventricular taurine: Specificity and relationship with central serotonin (5-HT) systems. J Pharmacol Exp Ther 219: 778–785.
Sgaragli GP, Frosini M, Palmi M, Bianchi L, Della Corte L. 1994. Calcium and taurine interaction in mammalian brain metabolism. Adv Exp Med Biol 359: 299–308.
Shain W, Bausback D, Fiero A, Madelian V, Turner JN. 1992. Regulation of receptor-mediated shape change in astroglial cells. Glia 5: 223–238.
Shen EY, Lai YJ. 2002. In vivo microdialysis study of excitatory and inhibitory amino acid levels in the hippocampus following penicillin-induced seizures in mature rats. Acta Paediatr Taiwan 43: 313–318.
Shibanoki S, Kogure M, Sugahara M, Ishikawa K. 1993. Effect of systemic administration of N-methyl-d-aspartic acid on extracellular taurine level measured by microdialysis in the hippocampal CA1 field and striatum of rats. J Neurochem 61: 1689–1704.
Shimada N, Graf R, Rosner G, Keiss WD. 1993. Ischemia-induced accumulation of extracellular amino acids in cerebral cortex, white matter, and cerebrospinal fluid. J Neurochem 60: 66–71.
Shupliakov O, Brodin L, Srinivasan M, Grillner S, Cullheim S, et al. 1994. Extrasynaptic localization of taurine-like immunoreactivity in the lamprey spinal cord. J Comp Neurol 347: 301–311.
Silva MA, Cunha GM, Viana GS, Rao VS. 1993. Taurine modulates chemical nociception in mice. Braz J Med Biol Res 26: 1319–1324.
Simpson RK Jr, Robertson CS, Goodman JC. 1990. Spinal cord ischemia-induced elevation of amino acids. Extracellular measurement with microdialysis. Neurochem Res 15: 635–639.
Singewald N, Zhou GY, Schneider C. 1995. Release of excitatory and inhibitory amino acids from the locus coeruleus of conscious rats by cardiovascular stimuli and various forms of acute stress. Brain Res 704: 42–50.
Smith A, Watson CJ, Frantz KJ, Eppler B, Kennedy RT, et al. 2004. Differential increase in taurine levels by low-dose ethanol in the dorsal and ventral striatum revealed by microdialysis with on-line capillary electrophoresis. Alcohol Clin Exp Res 28: 1028–1038.
Smith KE, Borden LA, Wang CH, Hartig PR, Branchek TA, et al. 1992. Cloning and expression of a high affinity taurine transporter from rat brain. Mol Pharmacol 42: 563–569.
Smith SS, Li J. 1991. GABAB receptor stimulation by baclofen and taurine enhances excitatory amino acid induced phosphatidylinositol turnover in neonatal rat cerebellum. Neurosci Lett 132: 59–64.
Smullin DH, Schamber CD, Skilling SR, Larson AA. 1990. A possible role for taurine in analgesia. Prog Clin Biol Res 351: 129–132.
SolÃs JM, Herranz AS, Herreras O, Lerma J, MartÃn del RÃo R. 1988a. Does taurine act as an osmoregulatory substance in the rat brain? Neurosci Lett 91: 53–58.
SolÃs JM, Herranz AS, Herreras O, Lerma J, MartÃn del RÃo R. 1988b. Low chloride-dependent release of taurine by a furosemide-sensitive process in the in vivo rat hippocampus. Neuroscience 24: 885–891.
SolÃs JM, Herranz AS, Herreras O, Muñoz MD, MartÃn del RÃo R, et al. 1986. Variation of potassium ion concentrations in the rat hippocampus specifically affects extracellular taurine level. Neurosci Lett 66: 263–268.
Song Z, Hatton GI. 2003. Taurine and the control of basal hormone release from rat neurohypophysis. Exp Neurol 183: 330–337.
Stipanuk MH, Londono M, Lee JI, Hu M, Yu AF. 2002. Enzymes and metabolites of cysteine metabolism in nonhepatic tissues of rats show little response to changes in dietary protein or sulfur amino acid levels. J Nutr 132: 3369–3378.
Stover JF, Morganti-Kosmann MC, Lenzlinger PM, Stocker R, Kempski OS. 1999. Glutamate and taurine are increased in ventricular cerebrospinal fluid of severely brain-injured patients. J Neurotrauma 16: 135–142.
Stummer W, Betz AL, Shakui P, Keep RF. 1995. Blood-brain barrier taurine transport during osmotic stress and in focal cerebral ischemia. J Cereb Blood Flow Metab 15: 852–859.
Sturman JA. 1993. Taurine in development. Physiol Rev 73: 119–147.
Sturman JA, Lu P, Messing JM, Imaki H. 1996. Depletion of feline taurine levels by β-alanine and dietary taurine restriction. Adv Exp Med Biol 403: 19–36.
Sturman JA, Moretz RC, French JH, Wisniewski HM. 1985. Taurine deficiency in the developing cat: Persistence of the cerebellar external granule cell layer. J Neurosci Res 13: 403–416.
Sundström E, Mo LL, Seiger Å. 1995. In vivo studies on NMDA-evoked release of amino acids in the rat spinal cord. Neurochem Int 27: 185–193.
Sung DY, Walthall WW, Derby CD. 1996. Identification and partial purification of putative taurine receptor proteins from the olfactory organ of the spiny lobster. Comp Biochem Physiol B Biochem Mol Biol 115: 19–26.
Sved AF, Curtis JT. 1993. Amino acid neurotransmitters in nucleus tractus solitarius: An in vivo microdialysis study. J Neurochem 61: 2089–2098.
Swain MS, Bergeron M, Audet R, Blei AT, Butterworth RF. 1992. Monitoring of neurotransmitter amino acids by means of an indwelling cisterna magna catheter: A comparison of two rodent models of fulminant liver failure. Hepatology 16: 1028–1035.
Tamai I, Senmaru M, Terasaki T, Tsuji A. 1995. Na+- and Cl−-dependent transport of taurine at the blood-brain barrier. Biochem Pharmacol 50: 1783–1793.
Tang XW, Deupree DL, Sun Y, Wu JY. 1996. Biphasic effect of taurine on excitatory amino acid-induced neurotoxicity. Adv Exp Med Biol 403: 499–505.
Tappaz ML. 2004. Taurine biosynthetic enzymes and taurine transporter: Molecular identification and regulations. Neurochem Res 29: 83–96.
Tchoumkeu-Nzouessa GC, Rebel G. 1996a. Characterization of taurine transport in human glioma GL15 cell line: Regulation by protein kinase C. Neuropharmacology 35: 37–44.
Tchoumkeu-Nzouessa GC, Rebel G. 1996b. Activation of protein kinase C down-regulates glial but not neuronal taurine uptake. Neurosci Lett 206: 61–64.
Theofanopoulos V, Lau-Cam C. 1998. Modification by taurine of the metabolism and hypothermic effect of ethanol in the rat. Adv Exp Med Biol 442: 309–318.
Thurston JH, Hauhart RE. 1989. Valproate doubles the anoxic survival time of normal developing mice: Possible relevance to valproate-induced decreases in cerebral levels of glutamate and aspartate, and increases in taurine. Life Sci 45: 59–62.
Tong X, Patsalos PN. 2001. A microdialysis study of the novel antiepileptic drug levetiracetam: Extracellular pharmacokinetics and effect on taurine in rat brain. Br J Pharmacol 133: 867–874.
Torp R, Andiné P, Hagberg H, Karagülle T, Blackstad TW, et al. 1991. Cellular and subcellular redistribution of glutamate-, glutamine- and taurine-like immunoreactivities during forebrain ischemia: A semiquantitative electron microscopic study in rat hippocampus. Neuroscience 41: 433–447.
Trachtman H, Barbour R, Sturman JA, Finberg L. 1988a. Taurine and osmoregulation: Taurine is a cerebral osmoprotective molecule in chronic hypernatremic dehydration. Pediatr Res 23: 35–39.
Trachtman H, Del Pizzo R, Sturman JA, Huxtable RJ, Finberg LH. 1988b. Taurine and osmoregulation. II Administration of taurine analogues affords cerebral osmoprotection during chronic hypernatremic dehydration. Am J Dis Child 142: 1194–1198.
Trachtman H, del Pizzo R, Sturman JA. 1990. Taurine and osmoregulation. III. Taurine deficiency protects against cerebral edema during acute hyponatremia. Pediatr Res 27: 85–88.
Trenkner E, El Idrissi A, Dumas R, Rabe A. 1998. Functional consequences of calcium uptake modulation by taurine in vivo and in vitro. Adv Exp Med Biol 442: 277–284.
Trenkner E, El Idrissi A, Harris C. 1996. Balanced interaction of growth factors and taurine regulate energy metabolism, neuronal survival, and function of mouse cultured cerebellar cells under depolarizing conditions. Adv Exp Med Biol 403: 507–517.
Tuz K, Peña-Segura C, Franco R, Pasantes-Morales H. 2004. Depolarization, exocytosis and amino acid release evoked by hyposmolarity from cortical synaptosomes. Eur J Neurosci 19: 916–924.
Uchida S, Kwon HM, Yamauchi A, Preston AS, Marumo F, et al. 1992. Molecular cloning of the cDNA for an MDCK cell Na+- and Cl−-dependent taurine transporter that is regulated by hypertonicity. Proc Natl Acad Sci USA 89: 8230–8234.
Uchiyama-Tsuyuki Y, Araki H, Yae T, Otomo S. 1994. Changes in the extracellular concentrations of amino acids in the rat striatum during transient focal cerebral ischemia. J Neurochem 62: 1074–1078.
Uemura S, Ienaga K, Higashiura K, Kimura H. 1991. Effects of intraamygdaloid injection of taurine and valyltaurine on amygdaloid kindled seizure in rats. Jap J Psychiatry Neurol 45: 383–385.
Usifoh CO, Lambert DM, Woulters J, Scriba GKE. 2001. Synthesis and anticonvulsant activity of N,N-phthaloyl derivatives of central nervous system inhibitory amino acids. Arch Pharm Pharmacol Med Chem 234: 323–331.
Varga V, Janáky R, Marnela KM, Gulyás J, Kontro P, et al. 1989. Displacement of excitatory aminoacidergic receptor ligands by acidic oligopeptides. Neurochem Res 14: 1223–1227.
Varga V, Kontro P, Oja SS. 1988. Modulation of GABA-ergic neurotransmission in the brain by dipeptides. Neurochem Res 13: 1027–1034.
Varga V, Marnela KM, Kontro P, Gulyás J, Vadász Z, et al. 1987. Effects of acidic dipeptides on aminoacidergic neurotransmission in the brain. Adv Exp Med Biol 217: 357–368.
Vinnakota S, Qian X, Egal H, Sarthy V, Sarkar HK. 1997. Molecular characterization and in situ localization of a mouse retinal taurine transporter. J Neurochem 69: 2238–2250.
Vitarella D, Di Risio DJ, Kimelberg HK, Aschner M. 1994. Potassium and taurine release are highly correlated with regulatory volume decrease in neonatal primary rat astrocyte cultures. J Neurochem 63: 1143–1149.
Vohra BP, Hui X. 2000. Improvement of impaired memory in mice by taurine. Neural Plast 7: 245–259.
Vohra BP, Hui X. 2001. Taurine protects against carbon tetrachloride toxicity in the cultured neurons and in vivo. Arch Physiol Biochem 109: 90–94.
Waagepetersen H, Melo T, Schousboe A, Sonnewald U. 2005. Homeostasis of neuroactive amino acids in cultured cerebellar and neocortical neurons is influenced by environmental cues. J Neurosci Res 79: 97–105.
Wade JV, Olsson JP, Samson FE, Nelson SR, Pazdernik TL. 1988. A possible role for taurine in osmoregulation within the brain. J Neurochem 51: 740–745.
Wade JV, Samson FE, Nelson SR, Pazdernik TL. 1987. Changes in extracellular amino acids during soman- and kainic acid-induced seizures. J Neurochem 49: 645–649.
Wahl P, Elster L, Schousboe A. 1994. Identification and function of glycine receptors in cultured cerebellar granule cells. J Neurochem 62: 2457–2463.
Walberg F, Ottersen OP, Rinvik E. 1990. GABA, glycine, aspartate, glutamate and taurine in the vestibular nuclei: An immunocytochemical investigation in the cat. Exp Brain Res 79: 547–563.
Walz W, Allen AF. 1987. Evaluation of the osmoregulatory function of taurine in brain cells. Exp Brain Res 68: 290–298.
Walz W, Hinks EC. 1985. Carrier-mediated KCl accumulation accompanied by water movements is involved in the control of physiological K+ levels by astrocytes. Brain Res 343: 44–51.
Wang DS, Xu TL, Pang ZP, Li JS, Akaike N. 1998. Taurine-activated chloride currents in the rat sacral dorsal commissural neurons. Brain Res 792: 41–47.
Wang F, Xiao C, Ye JH. 2005. Taurine activates excitatory non-synaptic glycine receptors on dopamine neurons in ventral tegmental area of young rats. J Physiol 565: 503–516.
Warburton DM, Bersellini E, Sweeney E. 2001. An evaluation of a caffeinated taurine drink on mood, memory and information processing in healthy volunteers without caffeine abstinence. Psychopharmacology 158: 322–328.
Ward R, Cirkovic-Vellichovia T, Ledeque F, Tirizitis G, Dubars G, et al. 2006. Neuroprotection by taurine and taurine analogues. Taurine 6. Oja SS, Saransaari P, editors. New York: Springer/Kluwer Academic; pp. 299–306.
Ward RJ, Kest W, Bruyeer P, Lallemand P, De Witte, 2001. Taurine modulates catalase, aldehyde dehydrogenase, and ethanol elimination rates in rat brain. Alcohol Alcohol 36: 39–43.
Ward RJ, Martinez J, Ball D, Marshall EJ, De Witte P. 2000. Investigation of the therapeutic efficacy of a taurine analogue during the initial stages of ethanol detoxification: Preliminary studies in chronic alcohol abusers. Adv Exp Med Biol 483: 375–381.
Wasserhess P, Becker M, Staab D. 1993. Effect of taurine on synthesis of neutral and acidic sterols and fat absorption in preterm and full-term infants. Am J Clin Nutr 58: 349–353.
Wu H, Jin Y, Wei J, Jin H, Sha D, et al. 2005. Mode of action of taurine as a neuroprotector. Brain Res 1038: 123–131.
Wu JY, Chen W, Tang XW, Jin H, Foos T, et al. 2000. Mode of action of taurine and regulation dynamics of its synthesis in the CNS. Adv Exp Med Biol 483: 35–44.
Wu JY, Johansen FF, Lin CT, Liu JW. 1987. Taurine system in the normal and ischemic rat hippocampus. Adv Exp Med Biol 217: 265–274.
Wu JY, Liao C, Lin CJ, Lee YH, Ho JY, et al. 1990. Taurine receptor in the mammalian brain. Prog Clin Biol Res 351: 147–156.
Wu JY, Lin CT, Johansen FE, Liu JW. 1994. Taurine neurons in rat hippocampal formation are relatively inert to cerebral ischemia. Adv Exp Med Biol 359: 289–298.
Wu JY, Tang XW, Tsai WH. 1992. Taurine receptor: Kinetic analysis and pharmacological studies. Adv Exp Med Biol 315: 263–268.
Wu ZY, Xu TL. 2003. Taurine-evoked chloride current and its potentiation by intracellular Ca2+ in immature rat hippocampal CA1 neurons. Amino Acids 24: 155–162.
Wysmyk U, Oja SS, Saransaari P, Albrecht J. 1994. Long-term treatment with ammonia affects the content and release of taurine in cultured cerebellar astrocytes and granule neurons. Neurochem Int 24: 317–322.
Yager JY, Armstrong EA, Miyashita H, Wirrell EC. 2002. Prolonged neonatal seizures exacerbate hypoxic-ischemic damage: Correlation with cerebral energy metabolism and excitatory amino acid release. Dev Neurosci 24: 367–381.
Yang R, Li Q, Guo JC, Jin HB, Liu J, et al. 2006. Taurine participates in the anticonvulsive effect of electroacupuncture. Taurine 6. Oja SS, Saransaari P, editors. New York: Springer/Kluwer Academic; pp. 389–394.
Ye GI, Tse ACO, Yung WH. 1997. Taurine inhibits rat substantia nigra pars reticulate neurons by activation of GABA- and glycine-linked chloride conductance. Brain Res 749: 175–179.
Ye JH, Wang F, Krnjević K, Wang W, Xiong ZG, et al. 2004. Presynaptic glycine receptors on GABAergic terminals facilitate discharge of dopaminergic neurons in ventral tegmental area. J Neurosci 24: 8961–8974.
Yingcharoen K, Rinvik E, Storm-Mathisen J, Ottersen OP. 1989. GABA, glycine, glutamate, aspartate and taurine in the perihypoglossal nuclei: An immunocytochemical investigation in the cat with particular reference to the issue of amino acid localization. Exp Brain Res 78: 345–357.
Yoshida M, Fukuda S, Tozuka Y, Miyamoto Y, Hisatsune T. 2004. Developmental shift in bidirectional functions of taurine-sensitive chloride channels during cortical circuit formation in postnatal mouse brain. J Neurobiol 60: 166–175.
Yoshida M, Izumi K, Koja T, Fukuda T, Munekata E, et al. 1986. Inhibitory effect of taurine on wet-dog shakes produced by [d-Ala2, Met3]enkephalinamide with reference to effects on hippocampal epileptic discharges. Neuropharmacology 25: 1373–1378.
Young RSK, During MJ, Donnelly DF, Aquila WJ, Perry VL, et al. 1993. Effect of anoxia on excitatory amino acids in brain slices of rats and turtles: In vitro microdialysis. Am J Physiol 264: R716–R719.
Young TL, Matsuda T, Cepko CL. 2005. The noncoding RNA taurine upregulated gene 1 is required for differentiation of the murine retina. Curr Biol 15: 501–512.
Yu K, Ge SY, Ruan DY. 2003. Fe2+ decreases the taurine-induced Cl− current in acutely dissociated rat hippocampal neurons. Brain Res 960: 25–35.
Yu K, Yu SS, Ruan DY. 2005. Opposite effects of lead on taurine- and HFS-induced LTP in rat hippocampus. Brain Res Bull 64: 525–531.
Yu S, Cai J. 2003. Effects of aniracetam on extracellular levels of transmitter amino acids in the hippocampus of the conscious gerbils: An intracranial microdialysis study. Neurosci Lett 339: 187–190.
Zhang M, Bi LF, Ai YD, Yang LP, Wang HB, et al. 2004. Effects of taurine supplementation on VDT work induced visual stress. Amino Acids 26: 59–63.
Zhao P, Cheng J. 1997. Effects of electroacupuncture on extracellular contents of amino acid neurotransmitters in rat striatum following transient focal cerebral ischemia. Acupunct Electrother Res 22: 119–126.
Zhao P, Huang YL, Cheng JS. 1999. Taurine antagonizes calcium overload induced by glutamate or chemical hypoxia in cultured rat hippocampal neurons. Neurosci Lett 268: 25–28.
Zheng L, Godfrey DA, Waller HJ, Godfrey TG, Chen K, et al. 2000. Effects of high-potassium-induced depolarization on amino acid chemistry of the dorsal cochlear nucleus in rat brain slices. Neurochem Res 25: 823–835.
Zhu WJ, Vicini S. 1997. Neurosteroid prolongs GABAA channel deactivation by altering kinetics of desensitized states. J Neurosci 17: 4022–4031.
Zielińska M, Hilgier W, Borkowska HD, Oja SS, Saransaari P, et al. 2002. Ammonia-induced extracellular accumulation of taurine in the rat striatum in vivo: Role of ionotropic glutamate receptors. Neurochem Res 27: 37–42.
Zielińska M, Hilgier W, Law RO, Goryński P, Albrecht J. 1999. Effects of ammonia in vitro on endogenous taurine efflux and cell volume in rat cerebrocortical minislices: Influence of inhibitors of volume-sensitive amino acid transport. Neuroscience 91: 631–638.
Zielińska M, Law RO, Albrecht J. 2003. Excitotoxic mechanism of cell swelling in rat cortical slices treated acutely with ammonia. Neurochem Int 43: 299–303.
Acknowledgments
The financial support of the Medical Fund of Tampere University Hospital is gratefully acknowledged.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer Science+Business Media, LLC
About this entry
Cite this entry
Oja, S.S., Saransaari, P. (2007). 8 Taurine. In: Lajtha, A., Oja, S.S., Schousboe, A., Saransaari, P. (eds) Handbook of Neurochemistry and Molecular Neurobiology. Springer, New York, NY. https://doi.org/10.1007/978-0-387-30373-4_8
Download citation
DOI: https://doi.org/10.1007/978-0-387-30373-4_8
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-30342-0
Online ISBN: 978-0-387-30373-4
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences